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Abstract
Breast cancer patients undergoing radiotherapy often experience severe levels of anxiety
and depression. There is a gap in the research literature from Africa, particularly from
Ghana, with few studies focusing on the assessment of anxiety and depression among
breast cancer patients undergoing radiation treatment. A better understanding was
essential to promote efforts to help breast cancer patients cope with their diagnosis and
treatment and increase their overall quality of life. This mixed method study examined
breast cancer patients in Ghana undergoing radiotherapy and their responses related to
anxiety and depression through a concurrent triangulation involving an interview with
selected professional participants and a detailed patient survey. Patients completed 2
modified scales, the Patient Health Questionnaire and Depression Anxiety Stress Scale.
The sample consisted of 100 patients between the ages of 20-89. Individual interviews
were held with 6 professionals with a minimum of 5 years of work experience. Themes
were generated through open coding of the interview data, while multiple regression was
performed to determine the relationship between depression and anxiety with the
independent variables . Findings of this study indicated the need intervene through
counseling and education on behalf of patients in Ghana as they undergo breast cancer
treatment. Age and monthly income of patients were statistically significant in predicting
the anxiety and depression among the patients. The study’s implications will lead to
positive change when all stakeholders take on the responsibility of implementing
measures to promote coping strategies for breast cancer patients in Ghana.
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Chapter 1: Introduction to the Study
Introduction
The interest to study anxiety and depression among cancer patients in Ghana
started with keen observation and note-taking that I conducted over 12 years as a
radiation therapist. The interest developed into a study and begun in 2014 with a focus on
breast cancer. Cancer treatment in Ghana is costly, with inadequate patient’s support
systems to cover treatment and chemotherapy drugs. These and many other multifactorial
reasons lead to several levels of anxiety and depression prevalent amongst the patients.
Anxiety is the feeling of fear, distress, and uneasiness of an imminent
endangerment (Antwi, Kyei, Gawugah, Opoku, & Ogbuokiri, 2015), and in the setting of
this study, anxiety was the central emotional distress among patients undergoing cancer
treatment. According to Bali, (2015), anxiety has both physiological and psychological
components. Depression is a symptom expressed through tireless sensations of
hopelessness, unhappiness, lack of concentration, lack of energy, and insomnia,
especially with a cancer diagnosis (Healthline, 2015). Breast cancer is the most common
cancer among women globally according to Ward et al., (2015), and the World Health
Organization (WHO) predicted it as the most likely reason a woman will die of cancer
(WHO, 2007). WHO, in their 2013 global estimates, indicated that cancer of the breast
was common in both the developing and the developed world with an estimated average
of over 508 000 deaths every year (WHO 2013). According to studies done in Ghana by
Wiredu & Armah, (2006) and Biritwum & Amaning, (2000), breast cancer is the
common cause of mortality and most hospital admissions among Ghanaian women.
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This study on anxiety and depression among breast cancer patients could
potentially influence breast care treatment and subsequently post treatment management
at all stages. Findings from the study could be used to modify treatment and supportive
care protocols for the management of breast cancers in Ghana.
Background of the Study
Cancer of the breast happens to be one of the most impactful diseases worldwide
and in Ghana; it accounts for the highest number of referrals at the study site. A study by
Gukas et al., (2005) in Ghana reported that breast cancer in the indigenous Black African
population is often severe, with unfavorable prognostic features. These functions include
age at presentation, diagnosis with advanced stages, high-grade histological subtypes,
large tumor size, and low rate of hormone receptor positivity (Ikeoluwapo et al., 2016).
These features are believed to explain why most African women are more likely to die
from the disease than women from developed countries (Ohene-Yeboah, & Adjei, 2012).
The treatment of breast cancer has evolved over the years, offering patients high
rates of survival (Scharl, Kühn, Papathemelis, & Salterberg, 2015). Several studies have
demonstrated that these patients are usually at greater risk of developing psychological
distress leading to some level of anxiety and depression (Arvidsdotter, Marklund, Kylén,
Taft, & Ekman, 2015; Schetter & Tanner, 2012). Furthermore, this distress link among
breast cancer patients extends to the post-treatment period with depressive and anxiety
disorders (Vin-Raviv, Akinyemiju, Galea, & Bovbjerg, 2015). According to studies by
Coolen, (2012) and Institute of Medicine Committee on Psychosocial Services to Cancer
Patients/Families in a Community Setting, (2008), clients receiving treatment have fears
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and concerns regarding mortality. Other concerns expressed by patients in the same study
were disease recurrence, body image impairment, especially with mastectomy, alteration
hormonal femininity treatment, and sexuality, as well as attractiveness with spouses and
loved ones.
Below are some selected articles involving assessment of anxiety and depression
among breast cancer patients:
•

Husson, Mols, and Van de Poll-Franse (2011) provided information through a
systematic review of the relation between health-related quality of life and
information provision, depression, and anxiety among cancer survivors.

•

Hassan et al. (2015) assessed breast cancer patients undergoing treatment,
their status and other contributing factors that lead to anxiety and depression.
They also looked at supports and care administered to participants with a high
risk of anxiety and depression.

•

Vahdaninia, Omidvari and Montazeri (2010) and Jacobsen and Jim (2008)
provided different psychosocial interventions for anxiety and depression in
adult cancer patients, in particular on the family and patients’ illness
characteristics. They also looked at factors that predicted levels of anxiety and
depression among breast cancer patients.

•

Research by Burgess et al. (2005) and Dauchy, Dolbeault, & Reich, (2013)
assessed anxiety and depression among breast cancer patients using
observational cohort studies focusing on the role of pain, the cancer type, and
the similar treatment.
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•

So et al. (2010) examined the level of anxiety and depression and their effects
on the quality of life of patients with breast cancer undergoing chemotherapy
or Radiotherapy.

•

Jadoon, Munir, Shahzad, & Choudhry, (2010) used a cross-sectional study to
assess anxiety and depression in adult cancer outpatients.

What was missing in the literature were studies that focused on determining levels
of depression and anxiety and how this assessment impacted treatment outcome for breast
cancer patients undergoing radiotherapy. A more complete understanding of these issues
resulting from this study promotes positive social change in three different ways. First, it
serves the cancer population, especially patients undergoing breast cancer treatment, to
help them manage depression and anxiety. Second, it enhances their efforts for coping,
and third, it increases the overall quality of life of these patients undergoing treatment.
This research has brought to light the significance of the level and the need to
assess breast cancer patients regularly while they undergo their treatment regime. This
study also addressed diagnosis and treatment of breast cancer and the overall workload of
the staff attending to patients undergoing treatment.
Problem Statement
Studies conducted by Watts, Prescott, Mason, McLeod, and Lewith (2015) and
Birnie, Garland, and Carlson (2009) have established that every cancer patient in their
cancer journey will at some point experience some degree of anxiety and depression. The
authors further indicated that this experience progresses during their treatment duration
and post treatment. The authors suggested that families do suffer from the effects of
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anxiety and depression in patients undergoing treatment. A phase of emotional shock and
disbelief is common as part of the patient’s psychological characteristics after a diagnosis
is made, followed by anxiety (Birnie et al., 2009).
According to Hassan et al. (2015), breast cancer is one of the most feared diseases
among women, and it could induce some level of changes of psychological disorders
such as anxiety and depression. According to a study by Kyei, Arthur, Vanderpuye, &
Antwi, (2008), the majority of breast cancer patients undergoing treatment at the study
site were not comfortable and satisfied with the trends of the radiation treatment they
received. This unsatisfactory nature was evidenced by the degree of complaints leading to
an intensification in their levels of anxiety and triggering many levels of depression
(Jadoon et al., 2010).
Among the study population, anxiety and depression are the most dominant
symptoms that are usually under predicted and undertreated from observations.
According to Joffe et al., (2012), depression and anxiety reduce the lifespan of patients
and affect their overall quality of life. Anxiety is common in patients with advanced
disease and associated with physical disability, augmented health difficulties, as well as
poor quality of life (Lenze & Wetherell, 2011). Depression, on the other hand, leads to
increased mortality, affects the total well-being of clients, and disturbs the daily
functioning of patients undergoing treatment (Martín-María et al., 2016).
Several studies including Hassan et al. (2015), Dauchy et al. (2013), and So et al.,
(2010) have been conducted in the developed world on anxiety and depression. This
research has led to a good understanding of some key features associated with anxiety
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and depression, though there is a gap in literature with Africa, particularly for Ghana.
Among all the research studies identified, only a few have focused on the assessment of
anxiety and depression among breast cancer patients undergoing radiation treatment
(Srivastava et al., 2016; Hassan et al., 2015; Chintamani et al., 2011; Dastan & Buzlu,
2010; Vahdaninia et al., 2010). These studies were mostly in India, Iran, Malaysia,
Turkey, and the United Kingdom. None of these studies have been done in Ghana, West
Africa, or even Africa at large to assess the level of anxiety and depression among breast
cancer patients undergoing Radiotherapy.
Purpose of the Study
With this study I aimed to find various interventions for depression and anxiety
among breast cancer patients in Ghana. I used a mixed method design to gather both
quantitative and qualitative data. The qualitative data were from interviews with selected
working participants while the quantitative data came from a non probabilistic approach
using a structured questionnaire to assess the severity and frequency of anxiety and
depression as well as the therapy and the quality of life experienced by patients
undergoing breast cancer treatment in Ghana.
Research Questions and Hypothesis
The research questions for this study were;
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing
radiotherapy with high-level anxiety and depression?
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RQ2-Quantitative: How does the effect of breast cancer stage, the cost of
treatment, and waiting time affect a patient’s level of anxiety, depression, and
treatment responses?
H0: There is no significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
H1: There is a significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
Theoretical Framework
The application of the health action process approach (HAPA) theory is essential
in this breast cancer assessment, and it is in the group of the behavioral theories
(Schwarzer, 2008). This theory is a psychological theory of health behavior change
developed by R. Schwarzer in 2008. The model was used to describe, predict, and explain
breast cancer treatment processes that lead to anxiety and depression. It was also used to
examine psychological concepts that mutually target and clarify what influences patients’
depression and anxiety during the treatment journey. The theory provided frameworks
that inform preventive action during the treatment trajectory. The study comprises three
stages:
1. the informed decision-making stage, through the help of the patients and
caregivers or family members;
2. the treatment stage; and
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3. The post treatment phase.
Nature of the Study
I used a mixed method design to gather both quantitative and qualitative data. The
interviews that were qualitative in this research were with some selected staff who
worked in close collaboration with patients (doctors, nurses, radiation therapists). The
quantitative data was a representative survey with questionnaire using a sample of 100
and with a non probabilistic approach because there was no appointment system for
patients undergoing treatment for the assessment. The selection of patients took place as
and when patients enrolled in the treatment after they signed indicating consent. A
collection of data for the study was done using a semi structured questionnaire that was a
modified version of Patient Health Questionnaire and the Depression Anxiety Stress
Scales. Patient demographics such as the age, sex, education, marital status, and income
level were measured. The period of treatment, waiting times, type of cancer, and the
remedy for the anxiety and depression experienced were measured as well.
Assumptions
In this study, the assumption was that the selection of participants who
volunteered to participate in the study was not biased. Another assumption was that the
participants (patients) responded to the questionnaire honestly, and the members of the
working team (professionals) reacted to the interview fairly. An additional assumption
was that I did not influence the responses of the participants on the items administered.
Finally, I assumed the sample to be representative of the entire population.
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Scope and Delimitations
The extent of the study involved the assessment of anxiety and depression during
their treatment trajectory as the independent variable and the relationship between the
responses of breast cancer patients as dependent variables. Also, there was a careful
examination of the anxiety and depression and how these affected the overall treatment
outcome. Through this study I assessed the relationships as listed in the research
questions and hypotheses. I used a convenient sampling of patients undergoing breast
cancer treatment in Ghana, and the population consisted of all breast cancer patients
referred to the Oncology Department of the Korle-Bu teaching hospital. There have been
few theories that relate to the problem statement; however, the only one that could relate
primarily to the core was the HAPA.
Limitations
A limitation of a study is the standard structures within the designs of the
methodology that set boundaries on the clarification of the results (Labaree, 2009). The
limitations of this study stemmed from three levels of issues. The first was the
recruitment of patient participants for the quantitative study. The plan was to select
patients before the start of radiation therapy. However, this limited the selection because
not every patient ended up being treated. In some instances, the cost of treatment alone
prevented patients from undergoing treatment; other occurrences included the death of
patients awaiting treatment and other multifactorial reasons. I planned to begin
recruitment directly from participants who had begun their treatment.
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The second limitation was the language barrier because not all the patients spoke,
read, or wrote in English. The plan was to help in translation into the local languages
where the need arose. I translated the questionnaire into the local language during the
data collection, and that assisted the whole process. Also, I excluded non-Ghanaians from
the study.
The third and final limitation was the fact that some patients did not respond
honestly to the survey questions for fear that the staff may wrongly interpret it. I
continuously assured patients to gain the firmest of confidence in their responses to the
questions.
Significance of the Study
Through the assessment of anxiety and depression among breast cancer patients
undergoing radiotherapy in Ghana, the study could offer oncology care teams (radiation
oncologists, radiation therapists, and oncology nurses) an understanding of the common
elements of anxiety and depression. Through the management of anxiety and depression,
the quality of life of breast cancer patients undergoing radiotherapy could improve,
particularly during their end-of-life stage. The expectation was that the study would
promote positive social change in the form of coping strategies and greater awareness of
the conditions of breast cancer with the aim of preventing it. The latter would occur
through various levels of cancer education to both the client and the caregivers. With the
coping strategies, patients undergoing treatment could benefit from daily tips on breast
cancer management from the oncology nurses.
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The contribution of the various coping mechanisms resulting from the survey
through the feedback of the patients undergoing treatments and the interactions with the
working staff could help alleviate these emotional symptoms and ensure the total wellbeing of the patients. The study examined factors that were critical and impacted patients’
overall treatment performance, future implications, and overall social life. Findings from
the study could also be used to plan policies that could support methods beneficial to the
advancement of oncological services in Ghana and Africa since many neighboring
countries in the West Africa patronize the oncology services in Ghana. The expectation
was that the study would inform family members and caregivers to make conscious
decisions on managing a patient during treatment and post treatment stages. Finally, the
possible positive social change resulting from the study could be seen globally and
locally by providing a basis for future research, especially regarding cancer and
depression and anxiety.
Summary
In the next chapter I review the literature of the various components of the study
centering on the main areas such as search criteria, the gap in the literature, the social
implication of the survey, and the HAPA theory and its influence on and alignment with
the study. I also look at breast cancer in Ghana and the need for awareness for early
presentation. Finally, I focus on the anxiety and depression, causes, symptoms,
prevalence, interventions, and the validity of the scales for the study.
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Chapter 2: Literature Review
Introduction
According to a study by Kyei, Arthur, Vanderpuye, & Antwi, (2008), the majority
of breast cancer patients undergoing treatment at the study site were dissatisfied with the
radiation treatment they received. This unsatisfactory nature was evidenced by the
various degrees of complaints leading to an intensification in the patients’ levels of
anxiety and triggering many levels of depression (Jadoon et al., 2010). This study
elucidated the various interventions required to minimize depression and anxiety among
breast cancer patients undergoing radiation therapy in Ghana.
In this chapter I review current literature in the field of public health and social
science. The search criteria covered areas such as breast cancers, a population in Ghana
with cancer of the breast, and those undergoing radiotherapy at the oncology unit at the
study site. The search further considered the Ghanaian culture and the level of
occurrences of breast cancer among the Ghanaian population. The review covers the
theory of the HAPA that I used as a framework for this study. This includes a review of
HAPA and its influence on the study as well as its alignment with the study. Also, there
is a thorough discussion of the risk factors of breast cancers and the associated levels of
anxiety and depression. The review also covers the causes, prevalence, symptoms,
assessment, disorders, and measures of depression and anxiety among breast cancer
patients. Finally, the literature search looked for information on ways to manage breast
cancer patients undergoing radiotherapy who presented with a high level of anxiety and
depression.
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Search Criteria/Description of Literature Search
A literature search conducted covered all areas of anxiety and depression. I
performed the search using various search engines such as Google Scholar, Academic
Search Premier, Medline, Psych Articles, EBSCOhost, PsycINFO, MEDLINE, PubMed,
Academic Search Complete, CINAHL Plus with Full Text, Cochrane Database of
Systematic Reviews, ProQuest, and SocINDEX. A thorough examination took place on
several physiological variables in breast cancer progression such as anxiety, depression
that extends to anger, blame, coping, helplessness, hopelessness, faith, hope, humor, and
optimism, among others. Several different sources such as Hofmann, Sawyer, Witt & Oh,
(2010), Satin, Linden & Phillips, (2009), and van’t Spijker, Trijsburg & Duivenvoorden,
(1996) were also helpful.
Furthermore, I reviewed a broader search through the reference lists of all
relevant studies carried out on the assessment of anxiety and depression among cancer
patients. I expected that the search would uncover all review articles and all materials
linked to this topic for additional review.
Gap in the Literature
Although several studies from the developed world have a good understanding of
some key features associated with anxiety and depression (e.g., Hassan et al., 2015;
Dauchy et al., 2013; So et al., 2010), there was a gap in the literature from Africa,
particularly for Ghana. Only a few studies had focused on the assessment of anxiety and
depression among breast cancer patients undergoing radiation treatment (Chintamani et
al., 2011; Dastan, & Buzlu, 2010; Hassan et al., 2015; Srivastava et al., 2016; Vahdaninia
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et al., 2010). These studies were from the India, Iran, Malaysia, Turkey, and the United
Kingdom. There had been no studies done in Ghana, West Africa, or even Africa at large
to assess the level of anxiety and depression among breast cancer patients undergoing
radiotherapy.
What was missing in the literature were studies that focused on assessing levels of
depression and anxiety and how this assessment impacted treatment outcomes for breast
cancer patients undergoing radiotherapy. Coming to a better understanding through this
study could promote positive social change in three different ways. First, it would serve
the cancer population, especially patients undergoing treatment, to manage depression
and anxiety. Second, it would enhance efforts for coping, and third, it could increase the
overall quality of life of these patients.
Social Implications of the Study
Depression and anxiety have significant roles in the coping mechanisms for
patients undergoing radiotherapy. Almost all patients at some point in their treatment
trajectory experience some level of anxiety and depression, but the severity and
management of this play a key factor in the survival of the patients. Issues with cancer
management have implications and side effects depending on the stage of disease.
Coupled with depression and anxiety could, for a variety of reasons, play a key factor in
patient mortality. This study could help improve the overall quality of life among
patients, their total well-being, their psychosocial functioning, and the overall patient
satisfaction with their treatment.
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As a result, several issues that arise from anxiety and depression with breast
cancer patients could decrease significantly. As described by Hofmann et al. (2010),
mindfulness that leads to a mental state without worry about the present experience could
be used as a therapy for patients undergoing breast cancer treatment. The results of that
study suggested that working on the minds of patients improves symptoms of anxiety and
depression (Hofmann et al., 2010). Hence, this assessment could be a memory-based
therapy for patients, and this could improve the social relevance of the study. The
significance of the survey could be the contribution of the various coping mechanisms
that will result in the review through the feedback of the patients undergoing treatments
and the interactions with the working staff. This could be important for the patients
undergoing treatment and any other patients referred to the oncology unit. It could also be
important for the working team who are in the position of ensuring the total well-being of
the patients. The study could help to re-examine factors that impact patients’ overall
treatment performance, future well-being, and social lives.
The study could potentially foster new policies in the three oncology units of
Ghana and the overall management of the treatment of cancer in the nation and beyond. It
may also inform the multidisciplinary team involved in the management of breast cancer
about the late presentation of breast cancer in Ghana. The implications for positive social
change could also include decreased depression and anxiety for late presenting breast
cancer patients as well as the effective management mechanisms for their caregivers. It
could also help project knowledge useful for the prevention of breast cancer.
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For this study, I explained the intervention required for depression and anxiety to
participants. Therefore, they could gain the courage to handle issues such as depression,
and that could help them to deal with a lack of outside support. All these could be
possible when patients are rightly informed about their conditions, stages, and the
possible treatment outcomes.
Theoretical Framework
Theories
In this study, I reviewed various models of health behavior change that provided
an outline of features that affected the entire study. In the study I examined one of the
components of the behavioral change theories, the HAPA. Behavioral change theories
usually try to describe why behaviors change and the environments conducive to change
(van der Linden, 2013). Several scholars have lately presented differences between the
theories of change and the models of behavior (van der Linden, 2013). However, these
changes of principles are more practice-oriented and usually aimed at changing a given
behavior, whereas the models of behavior are more analytical and typically trend towards
understanding the psychological factors that explicate or envisage an exact response
(Chatterjee & Das, 2015).
Health Action Process Approach
HAPA is a psychosomatic change theory of health behavior developed by R.
Schwarzer in 2008. The HAPA postulates at least two distinct stages, a motivation or preintentional phase and a volition or self-regulatory or action phase. In the motivation
phase, three variables are held to influence intention directly, the risk perception or the
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risk awareness, the outcome expectancies, and the self-efficacy (Schwarzer, 2004). The
volition phase is further divided into three stages, the planning phase, the initiation phase,
and the maintenance phase (Figure 1).

Figure 1: The HAPA, adapted from Schwarzer, 2004

Influence of the Health Action Process Approach on the Study
The HAPA was used to predict, describe, and explain breast cancer treatment
processes that lead to anxiety and depression. HAPA is a clear outline of several
motivational and volitional concepts used in the explanation and the prediction of
individual changes in health behaviors among breast cancer management. When applying
the HAPA model to breast cancer management, one of the preeminent predictors of
intention that represents the true nature of the conditions of the clients is self-value.
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However, planning has also been proven to be a primary predictor of the actual behavior
(Luszczynska & Schwarzer, 2003).
For the motivational phase of this study, the issues arising were the growing risk
awareness for patients undergoing treatment, and their level of outcome expectancies as
described extensively in the study of Schwarzer et al., (2003). In this phase, also, there
was a level of concern usually seen as a threat to the patients on their level of survival
and coping with the treatment. These threats may be due to the unestablished
expectancies and news about other patients who have undergone treatment. The patient's
beliefs also characterize this phase of the treatment and the known alternative or
traditional treatment. This period ends with a formation of a clear behavioral intention
towards the treatment received that will result in survival (Schwarzer et al., 2003). In the
volitional stage, once there was an intention to change a health behavior, such change
must be planned, introduced, and sustained (Schwarzer, 2008). Plans were made to
accommodate and manage some level of relapses which may occur during the study.
Alignment of the Health Action Process Approach With the Study
I used the theory to describe, predict, and explain breast cancer treatment
processes that lead to anxiety and depression. I also used it to examine a series of
psychological concepts that also clarify what encourages patients to feel depressed and to
be anxious at some point in the treatment journey. Finally, I used the theory to look at
frameworks that informed patients how to take preventive action at some point in their
treatment trajectory. In doing these, the study involved three stages:
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1. the informed decision-making stage, through the help of the patients and
caregivers or family members;
2. the treatment stage; and
3. The post treatment phase.
Breast Cancer in Ghana
Breast cancer treatment follows a treatment depending on the stage and the type
of disease. It is usually a multidisciplinary approach comprising Surgery, Radiotherapy,
Chemotherapy, and Hormonal therapy. The specialists provide the opportunity of
multidisciplinary diagnosis and treatment for patients. The experienced team in one’s
field delivers this service with the devices of technology. Apart from these, there are
other supportive services like disease management of breast cancer, nutrition and genetic
counseling, psychosocial support programs, and physical therapy (WHO, 2017). For
Surgery, there is a Mammoplasty, Tissue expansion, Lymph node dissection,
Lumpectomy, and Mastectomy. Mammoplasty has to do with plastic surgery to increase
or reduce the size of the breasts or to reconstruct a breast.
Tissue expansion is the process of inserting a balloon under the skin and then
gradually expanding it to stretch and grow the skin and surrounding tissue. Lymph node
dissection is simply the surgical removal of a lymph node. Lumpectomy is the surgical
removal of a lump (tumor) in the breast. Finally, mastectomy is the surgical removal of
some or all of the breast. The medical procedure is the Radiation Therapy which is the
use of high-energy beams to destroy cancer cells and shrink tumors. Chemotherapy is
basically through medications to kill cancer cells. The latter and Radiation therapy
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usually take place at the Oncology Department and the study will focus on patients
undergoing radiation treatment, irrespective of whether they have had surgery or
chemotherapy.
The Oncology Department of Accra, Ghana, is the Nation’s referral center for all
malignant disease in Ghana. It also serves as a cancer center for several neighboring West
African countries such as Togo, Benin, Cote d’Ivoire, Senegal, Burkina Faso, Guinea,
among others. It is one of the three Oncology departments within the country, serving the
southern Ghana and other foreigners referred. The other two are the Oncology
Department of Kumasi and the Swedish Ghana Medical which is a Private firm between
the Ghana Government and the Swedish Government.
The breast cancer population from the year 2012, 2013, 2014 and 2015 received
from the cancer registry at the Oncology Department in Accra were 479, 456, 431, and
513 respectively. Out of these population, the patients who ended up having their
radiation treatment aside surgery, chemotherapy, and hormonal therapy, were 307, 280,
257 and 349 within 2012, 2013, 2014 and 2015 respective years.
Patients Flow and Staff
The department has in all five units that will serve the entire breast cancer
population. There is the Clinic, which will be the first point of call for the patients when
referred and where Oncologists will decide whether the related case will require
radiotherapy or not. The second will be a pre-planning decision called the Simulation
before radiotherapy. The third will be the Planning unit which will see to the treatment
preparation of the breast cases and the prescription of the doses for treatment. The fourth
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stage will be the Mold room where the field of the treatment will be defined and finally
the treatment stage where the actual dose will be delivered to the breast as prescribed.
The working staff will be the Oncologists, Radiotherapists, the Medical
Physicists, and the Oncological Nurses. These will together manage, plan, treat, and
review patients that will be undergoing breast cancer treatment.
Culture Against Breast Cancer
According to the Africa Watch magazine in 2015, breast cancer is associated with
high mortality in many women in sub-Saharan Africa, though treatment is available
within the continent (Debrah, 2015). WHO (2015) revealed a total of 2,000 Ghanaian
women diagnosed with breast cancer in 2012, and 50% of these cases died. With early
breast cancer, curative treatment is possible, and the author quoted the 2014 recipient of
the Trust Women Journalist Award and the winner of the 2015 African Story Challenge,
Chika Oduah; ‘Many African languages do not have a word for the cancer disease.’ In all
research studies conducted within West Africa by several researchers, approximately six
out of eight women will die from the various level of late breast presentation
(Ikeoluwapo, Adetola, Adenike, et al., 2016; Ohene-Yeboah, & Adjei, 2012; Gakwaya,
Kigula-Mugambe, Kavuma, et al., 2008). However, the reverse occurred in the developed
countries where approximately six out of eight women were likely to survive breast
cancer after treatment (Assi et al., 2013; Ferlay et al., 2010).
The Africa Watch reports that most of the African women seek help and support
from alternative healers such as priests, herbalists or spiritual healers even before they
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think about the hospital, which in the end precariously delays and prolongs their disease
(Tammemagi, 2007).
Contributing Factors to Breast Cancer and Their Impact on the Study
Being a woman is one of the primary risk factors for developing breast cancer.
Though men can develop breast cancer (1/100), the disease is more common among
women than men according to the American Cancer Society (ACS), (2013). Also, 1/8 of
all invasive breast cancers are in women younger than 45 years, and 2/3 of all invasive
breast cancers are in women over 55 years (ACS, 2013). According to Allicock, Graves,
Gray, & Troester, (2013) and Clegg-Lamptey & Hodasi, (2007) possible reasons are
explaining why most African women are more likely to die from breast cancer compared
to women from other middle and high-income countries. These factors include a
presentation at a young age, diagnosis with advanced stage, large tumor size, high-grade
histological sub-types and low rates hormonal receptor positivity (Ohene-Yeboah &
Adjei, 2012).
A study conducted by Ohene-Yeboah & Adjei, (2012) indicated that there had
been several differing views of a stage of presentation in Ghana, the lack of awareness
and the availability of screening schemes which in the end contribute to the overall
survival of the patients. From studies reported by ACS, (2013) 5-10% of all breast cancer
cases are believed to be hereditary, resulting from genetic defects called mutations,
inherited from a parent. Several other studies have reported the low levels of education as
well as lower socioeconomic status associated with a delayed presentation of breast
cancer (Ohene-Yeboah & Adjei, 2012; Elgaili, Abuiris, Rahman, et al., 2010). This low
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education resulted in low levels of knowledge, causes, and complications of breast cancer
within Africa and Ghana (Briggs et al., 2010).
These concerns in Ghana, from the social point of view, keep compounding
especially with only two public radiotherapy centers and one private. There is also the
lack of a national breast cancer screening program, which echoes the frail health care
system in Ghana as well as the poor access to health facilities reported by Ohene-Yeboah
& Adjei, (2012). There are also constraints in resources within the Oncology setting
regarding staffing, equipment, and spacing. Again, the cost of breast cancer care is high
in Ghana because the National Health Insurance does not cover the total cost of therapy
and patients are required to make payments for their treatments (Opoku, Benwell, &
Yarney, 2012).
All these factors suggest a critical implication of the study in one way or the
other. First, women in the African perspective specifically in Ghana are seen as the
weaker vessel within the family, and therefore, a combination of the effect of a diagnosis
of breast cancer could cause them into some level of anxiety and depression. Also, many
of the women presenting breast cancer in Ghana are illiterate, and that puts more burden
on them regarding the coping strategies needed for the management of breast cancer.
Finally, the cost of treatment is a major blow to patients, because the ordinary Ghanaian
will have to pay the treatment themselves. Payment of complete cancer treatment could
take on their whole life savings, especially when they have a minimal or no support or
help from any family member, organizations, or even political, corporate bodies.
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Cost of Breast Cancer in Ghana
Breast cancer treatment and its related cost are financially straining for patients
and their caregivers in Ghana. Referrals are delayed unnecessarily due to patient’s
noncompliance and cost of treatment amongst other things. Although efforts to enroll
breast cancer diagnosis, treatment, and management to the Ghana’s National Health
Insurance Scheme (NHIS) has not been entirely successful, part of Surgery has been
absorbed (Hughes, Amoah, Ahiabor, & Awuah, 2012). Data from NHIS, (2010) indicates
that only 34% of the population of Ghanaian, had an active membership and that shows
that only 34% of cancer patients can access the scheme for Surgery. For Radiotherapy,
Chemotherapy, and hormonal therapy, the patients bear most of the cost, and these are
very expensive. This cost of treatment is, dependent on the stage of the disease according
to Warren, Yabroff, Meekins, Topor, Lamont, & Brown, (2008) and the cost of care
continuum is a scary factor. Advanced stages have increased cost compared to a lesser
value for early stages and early diagnosis (Ginsberg, Lauer, Zelle, Baeten, & Baltussen,
2012).
Currently, the authorities base the cost of Radiotherapy for breast cancers on the
stage and the intent of the disease. The average treatment cost of breast cancer treatment
at the study site in Accra, Ghana is between the ranges of $ 1,000 - $2,000.
Chemotherapy, on the other hand, ranges from $1000-$7,000 for multi-agent protocols.
Given the limited resources in Ghana and the fact that the average Ghanaian does not
earn that much income, there is the need for interventions for funding. Zelle, Nyarko,
Bosu, et al., (2012) identified that cost-effectiveness analysis which relates to the effects
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of interventions in health and cost of treatment, could help guide decision makers in
breast cancer management in Ghana.
The deliberations of the cost of breast cancer in Ghana and its impact on patients
undergoing radiation treatment at the study site will be incomplete without the
consideration of the impact of such burden on the economic barriers of the average
Ghanaian woman seeking for screening and treatment (Opoku, Benwell, & Yarney,
2012). In the study by Opoku et al., (2012) patients expressed their displeasure on the
high cost of radiation treatment and the encumbrance it places on themselves, families
and their overall lifetime savings. The authors indicated that such burden could
significantly affect the overall treatment outcome for patients.
There is currently no comprehensive and systematic cancer control policy for
breast cancer treatment in Ghana (Zelle, et al., 2012). There is also very low costeffectiveness of cancer control in Ghana or any other low-income country (Zelle &
Baltussen, 2013). The treatment of breast cancer guidelines is virtually vague, and
radiotherapy is available in only two largest cities in Ghana, generating essential barriers
regarding geographical access. The development of a National Cancer Registry is also at
the primary stage according to Vanderpuye, (2012) resulting in difficulties in the accurate
estimation of the national cancer burden in Ghana. Vanderpuye further reiterated that a
comprehensive information on the distribution of diseases at the regional levels would
help to ensure adequate resource use, appropriate access and the provision of care to all
Ghanaians (Vanderpuye, 2012).
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Globally, the literature on the cost of breast cancer treatment emphases is largely
in high-income countries (Ginsberg, Lauer, Zelle, Baeten, & Baltussen, 2012). As a
result, extrapolation of the cost to the low-income countries becomes difficult due to the
several variations in context. A typical example is the breast screening programs, wherein
the advanced environments, different age groups and target tool programs are used
differently from what happens in the developing settings (Anderson, Cazap, Saghir et al.,
2011). Table 1 shows some of the interventions for breast cancer control currently
ongoing in Ghana.
Anxiety and Depression as Risk Factors for Breast Cancer
Risk factors for breast cancers increase the incidence of the populace developing
breast cancer. Several risks factors such as family history, age, and medical history are
beyond the control of clients. The monitoring of other factors such as the weight of the
participants and alcohol consumption is also possible. The plan will be to conduct
literature searches with anxiety and depression as a risk factor for breast cancer.
Jacques (1998) identified that women with depressed mood due to an increased
rate of black bile were likely to develop breast cancer and this result supported an
association between the occurrences of breast cancer and some psychosocial factors
(Hong & Tian, 2014). Other studies have also examined the risk of breast cancer and
some stressful life events that could result in anxiety and depression (Yang et al., 2017;
Metcalfe et al., 2013). In another study, there was an evaluation of the risk of breast
cancer with some criteria for stressful life (Lin et al., 2013). The death of a spouse, death
of a relative or close friend, health crisis, marital difficulties, financial crisis, and their
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risk of developing breast cancer were identified as associated factors (Lin et al., 2013). At
the end of the study, there were reports on two indicators. The first was that there was no
evidence between a stressful life and breast cancer development and second was no
indication of stressful life and the increased risk of recurrence (Lin et al., 2013).

Table 1
Various Individual Interventions for Breast Cancer Control in Ghana According to the
Stages at Presentations by Zelle et al. (2012).
Stage

Treatment

Stage I & II

1. Lumpectomy with
axillary dissection
2. Radiotherapy
3. Systemic therapy

Stage III

1. Modified Mastectomy
2. Adjuvant Chemotherapy
3. Radiotherapy
4. Hormonal therapy and
possibly more
chemotherapy
1. Palliative systemic
therapy
2. Palliative radiotherapy
3. End of life
hospitalization
4. Total mastectomy for
eligible patients and
hormonal therapy

Stage IV

Down-staging
interventions
-Creating the Awareness
-Education on breast selfexamination

Palliative care
Supportive care
Pain
management
Psychosocial
care

-Biennial clinical breast
examination for women
aged 40–69 years
- Active community
outreach screening
-Palliative Care
-Volunteers training
program
-Home-based visits every
fortnight
-Pain treatment with
morphine, laxatives
-Palliative Radiotherapy for
eligible patients.

Diagnosis of Anxiety and Depression Among Breast Cancer
The incidence of anxiety and depression among breast cancer patients appears to
be reliant on several factors including the severity of the disease, performance status,
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patient’s disability level, and patient’s history (Sogaard, Thomsen, Bossen, Sorensen, &
Norgaard, 2013; Aapro & Cull, 1999). Somerset et al., (2004) on the other hand were of
the view that those significant symptoms of anxiety and depression are underestimated
and undertreated in women with breast cancer. One of the explanations given by
Greenberg (2004) was that women with breast cancer were hesitant to reveal their
emotional concerns. Chou, Kuang, Lee, et al., (2016) also indicated that cancer care
teams are mostly not familiar with such symptoms screening. The suggested diagnostic
features that could be for anxiety and depression among breast cancer patients according
to Mura, Bhat, Pisano, et al., (2012) are; history of psychiatric ailment, pain, lack of close
relatives, race, ethnicity, and personality.
Anxiety and Depression Among Breast Cancer Patients
Breast cancer according to Hassan, et al., (2015) is one of the most feared
diseases among women, and it could induce some level of changes of psychological
disorders such as anxiety and depression.
Causes of Anxiety and Depression Among Breast Cancer Patients
There are several reasons for of the depression and anxiety experienced amongst
breast cancer patients undergoing treatment. Identified causes could be physical,
psychological, emotional, environmental, social and spiritual as indicated by the National
Institute of Mental Health, (2014). Possible physical causes that affect breast cancer
patients during treatment could be the waiting time, the cost of therapy, and nutritional
problems such as loss of appetite. For psychological causes, there are nervousness,
touchiness, issues with sleep, and level concentration (National Institute of Mental
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Health, 2014). Other emotional reasons could be single status and breakups in marriages
as a result of the disease (CDC, 2012). Other social factors could be the staff-patients’
relationship, and Spiritual factors such as the fear of treatment, death, and the unknown
(CDC, 2012). With breast cancer, though the causes of anxiety and depression are most
times not the same, they usually occur at the same time.
Prevalence of Anxiety and Depression in Breast Cancer Patients
According to Baqutayan, (2012) anxiety is one of the leading psychological
challenges associated with cancer. In effect, every cancer patients undergo a level of
anxiety at some point in their disease trajectory. This level of concern, however, increases
as patients identify how severe their breast condition is with the stage of presentation and
how the treatment progresses. It is also essential to note that levels of anxiety differ from
patients to patients, and stages to stages and therefore management will be different from
every patient undergoing treatment. Depression, on the other hand, is a standard clinical
unit with a lifetime risk and the most common psychiatric problem faced by breast cancer
patients (Holland, 2010). The diagnosis of breast cancer is itself a marked stressor, and
therefore patients tend to get an added psychosocial and biological stressor that
accompany cancer and further raises the likelihood of becoming depressed.
Breast cancer patients usually may experience anxiety and depression at different
stages of the cancer treatment while undergoing radiotherapy and antedating a recurrence
of their breast cancer. This experience may result in their feelings of pain, disturb their
sleeping patterns, causes vomiting and nausea and affect their overall quality of life.
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Symptoms of Anxiety and Depression in Breast Cancer Patients
The expression of the symptoms of anxiety and depression among breast cancer
patients undergoing radiotherapy may be masked. Usually, breast cancer patients
undergoing treatment experience persistent sadness, changes in their mood feelings of
pessimism, and the sense of hopelessness (Steiner, Wagner, Bigatti, & Storniolo, 2014).
Others have a sense of guilt, helplessness, and worthlessness. There is also sometimes the
loss of interest or the loss of pleasure in the usual activities (Anxiety and Depression
Association of America (ADAA), 2016). Others also experience levels of fatigue,
decreased energy level and a feeling of some degree of slowness in life. At some point in
time, there is a difficulty in remembering events, concentrating on matters, and decisions
making. There is also the decrease in appetite, loss of weight, overeating, and overweight.
Other times, there is insomnia, oversleeping, restlessness, and irritability (ADAA, 2016).
In extreme cases, there are thoughts of death or suicide, and suicidal attempts by the
patients (ADAA, 2016).
Interventions and Treatment of Anxiety and Depression
Psychological. There is a considerable influence on the consequences of anxiety
and depression in patients undergoing treatment, and this effect decrease patient’s ability
to live independently (Rozzini, Chilovi, Peli, et al., 2009). There is also an upsurge of the
high risk of depression and anxiety among breast cancer patients on the advancement of
Alzheimer's disease (Lu, Edland, Teng, et al., 2009). Azermai, Petrovic, Elseviers, et al.,
(2012) recommended in their study that the treatment of the symptoms of depression and
anxiety should be a critical component of the overall treatment of Alzheimer's disease, as
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part of interventions to management. One of the studies reviewed found that the extent of
illness and physical impairment from treatment undergoing breast cancer treatment could
predict the mood disturbance of patients (Bagheri & Mazaheri, 2015). The results also
indicated that general satisfaction and quality of life also influence the overall
psychological interventions.
Moreover, issues with the degree of sexual indisposition have a psychological
impact on breast cancer patients undergoing treatments and this can be disturbing. In a
study by Ives, Saunders, Bulsara & Semmens, (2007) women who survived breast cancer
after treatment and later conceived were 37% (45/174) compared to the population
reviewed. In their conclusion, the authors concluded that the treatment of breast cancer
has a negative impact on procreative opportunities for women of childbearing age.
Additionally, there is the psychological effect on the family and extended members of
patients as a result of the treatment. These effect changes in the identity of the family,
daily functioning and the extent to the roles they play. A study by Woźniak & Iżycki,
(2014) documented that spouses of patients undergoing treatment were as distressed as
cancer patients. The study concluded that there is a correlation between distressed
patients and their partners.
Cognitive-behavioral therapy (CBT), is one of the many interventions for
managing depression and anxiety. According to ADAA, (2016) CBT can teach
participants undergoing treatment, ways to manage their fears and other symptoms they
expressed as a result of their level of anxiety and depression. According to ADAA (2016)
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could be done by finding the problem and taking control of their emotions. This therapy
will also involve the facing of one’s fears on the pathway to recovery.
Physical. Physical activity (exercise) deals with a broad range of health benefits
such as improving care and decreasing the level of anxiety and depression in cancer
patients (Stewart, & Wild, 2016). The absence of this can lead to detrimental effects on
the clients and increase the risk for other conditions other than cancer such as diabetes,
heart disease, obesity, and hypertension. According to Helgadóttir, Forsell, & Ekblom,
(2015), physical activity is linked with an improved physical health as well as the life
satisfaction of patients and their well-being. One of the systematic review studies by
Stonerock, Hoffman, Smith, & Blumenthal (2015), supported the use of exercise as a
treatment for depression and indicated that activity relates positively to antidepressant
medications for mild to moderate depression. Exercise has again been shown to improve
depressive and anxiety symptoms when used as an adjunct to medicines (Danielsson,
Noras, Waern, & Carlsson, 2013).
Physical therapy according to (Carek, Laibstain, & Carek, 2011) is usually linked
with declined level of anxiety and depression. Physical therapy according to Carek et al.,
(2011) releases chemicals in the body that makes people feel good and relax and
therefore the advice is practice the exercises such as only walking for 10 minutes and one
will have his or her symptoms assuaged.
Meditation. Meditation is one of the mental strategies that could be employed by
patients undergoing radiotherapy of the breast to manage depression and anxiety (Goyal,
Haythornthwaite, Levine, et al., 2010). Many cancer patients meditate to lessen the stress
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them and to forget about the health-related pain they undergo (Khoury, Lecomte, Fortin,
et al., 2013). The characteristics of meditative techniques are accentuating mindfulness,
attentiveness, and self-transcendence (Travis & Shear, 2010). Typical techniques, such as
mystical meditation, emphasize the use of an intonation in such a way that it transcends
one to an effortless state where focused attention is vague (Chiesa & Malinowski, 2011).
Another technique is mindfulness, and this is seen to improve the quality of life of
patients and simplify the symptoms of both anxiety and depression. Other meditative
practices are assimilated into a wider marginal approach that includes dietary and
movement therapies (Goyal et al., 2010).
Spirituality. The term spirituality is the cognizance of a power greater than the
individual self that gives purpose and meaning to the life (Geffen, 2010). It is the sense of
touch with the spiritual self and espousal of the connectedness to a higher authority.
According to Kessler, Wischnewsky, Michalsen, et al., (2013), spirituality is a journey
where an individual learns about the inner self, and then desires to be connected to the
Supreme Being and such route is believed to help accomplish peace of mind and healing
from within. According to the authors, this is achievable when anxiety, and depression,
which succeed in a wobbly and a nomadic mind, will cease to exist.
The word ‘Cancer’ stimulates a spiritual crunch in many clients undergoing
treatment, and for these individuals, the feeling of anxiety, anger, and depression is
discouraging (Romero, Friedman, Kalidas, et al., 2006). As these patients explore to find
the actual meaning in their lives and relationships, spirituality becomes helpful and
therapeutic especially in the African context (Gibson, & Hendricks, 2006). According to
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Puchalski, (2012), there are enormous benefits of integrating spirituality into cancer
treatment, and this includes decreasing the level of anxiety, anger, discomfort, loneliness,
depression, and risk of suicide for patients. According to Hofmann et al. (2010),
spirituality can play a fundamental role in the healing of patients with anxiety and
depression. One of the therapies within the African context is spirituality, and this is
essential because many people attach a spiritual meaning to whatever they go through
especially with a diagnosis of cancer (Kyei et al., 2015).
Pharmacological. Contemporary pharmacological treatments for anxiety and
depression according to Farach, Pruitt, Jun, et al., (2012) are safer and more tolerable
than previously used, though the effectiveness of the treatment and duration have not
improved in most cases. Currently, there are pharmacological approaches for the
management of depression and anxiety in dementia patients, but this according to Gitlin,
Kales, & Lyketsos, (2012), the side-effects could be bad that it makes the overall
treatment fundamentally ineffective. Medications could also be therapies for the
treatment of depression and anxiety. Reich, et al., (2008) indicated that drugs with
selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake
inhibitor (SNRI) help in the management of depression and anxiety in breast cancer
patients. There could also be a combination of psychotherapy and medication treatment
in achieving this. Finally, Antidepressant drugs may be administered to help treat both
anxiety and depression.
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Validity of Anxiety and Depression Symptoms Scales
A search of the literature on the scales for measuring anxiety and depression took
place on various search engines. This search found out how important this quest was in
meeting the goals of the research and whether some key advantages or shortfalls could
improve the proposed scales for this study as seen in the methodology. Few of the scales
that the investigator had come across were the Mood and Anxiety Symptom
Questionnaire (MASQ) initially by Watson & Clark, (1991) but modified in several
studies (Lee, Kim & Cho, 2015). The other was the Depression Anxiety Stress Scale by
Fernando Gomez (Henry & Crawford, 2005). Others are the Hamilton Anxiety Rating
Scale (Shear et al., 2001), the Dukes Anxiety-Depression Scale (Parkerson Jr &
Broadhead, 1997), and much more.
Summary
This chapter reviewed all items regarded as significant in the study. It started with
a search for all the literature on the topic, followed by an identified gap in literature
within Africa and particularly at the study center. The theoretical framework developed,
and the investigator proposed HAPA for the assessment of anxiety and depression. The
investigator reviewed the influence and the alignment of HAPA with the study. There
was also a major review of breast cancer in the Ghanaian populace, the culture,
contributing factors, and the impact on the study. There was also a discussion of the cost
of breast cancer which is a significant burden to patients. The investigator again looked at
the risk, diagnosis, causes, prevalence, symptoms and the interventions of breast cancer
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within the country and beyond. Finally, there was a review of the validity of the scales to
be used.
The next chapter focused on the methods employed for the study. The gap in the
literature studies centered on assessing levels of depression and anxiety and how this
assessment impacted treatment outcome for breast cancer patients undergoing
radiotherapy. With the use of the mixed method design, the investigator focused on the
evaluation using both quantitative and qualitative pathway, and this could possibly affect
the overall treatment of patients.
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Chapter 3: Methodology
Introduction
Through this study I aimed to find various interventions for depression and
anxiety among breast cancer patients in Ghana. I used a combination of qualitative and
quantitative data through a concurrent triangulation involving an interview with some
selected professional participants and a detailed survey. The triangulation method was to
show how the interviews supported, confirmed, or disconfirmed the responses from the
patient participants. This mixed method approach had a higher weighted scale of the
quantitative segment with both closed and open-ended questionnaires. I present the data
collection, data management, and data analysis in this chapter together with a discussion
of ethical issues of the research.
Research Methodology
The study approach was a mixed method design to gather both quantitative and
qualitative data with a primary concern for quantitative data. The qualitative data were
interviews with selected staff who worked in close collaboration with patients (doctors,
nurses, and radiation therapists). The quantitative data was a descriptive survey with
questionnaire using a sample of 100 participants and with a non probabilistic approach
because there was no appointment system for patients undergoing treatment for the
assessment. Patients were selected when they commenced treatment and consented to
partake in the study.
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Setting and Sample
The study took place at the oncology unit of the Korle-Bu Teaching Hospital,
Accra, Ghana between the proposed months of June and July 2017. The Korle-Bu
Teaching Hospital is the nation’s primary referral unit for cancer management with an
approximately 2,000 hospital bed capacity. I chose this for the study site because it serves
a total of 70% of all cancer cases seen in the country according to Kyei, Opoku, Antwi,
and Engel-Hills (2015). The use of convenience sampling occurred for the study because
it offered me access to both the participants (patients and professionals) and data
required. I used a power analysis to determine the appropriate sample size for the study
using G*Power 3.1 software (Faul, Erdfelder, Lang, & Buchner, 2007) as shown in to
Figures 2 and 3 below. The computed sample size was 89 with a power of 0.98.

Figure 2. Computing sample size.
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Figure 3. Range of values for 3-Power analysis.

Research Questions and Hypothesis
The research questions for this study were
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing
radiotherapy with high-level anxiety and depression?
RQ2-Quantitative: How does the effect of breast cancer stage, the cost of
treatment, and waiting time affect a patient’s level of anxiety, depression, and
treatment responses?
H0: There is no significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
H1: There is a significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
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Qualitative Interviews and Quantitative Survey
Interviews with six selected participants formed the qualitative aspects of this
study. These interviews involved semi structured questions asked of the chosen
participants (two in each professional category). The selected members included two
radiation oncologists, two radiotherapists, and two oncology nurses who worked in close
collaboration with the patients. On a daily basis, these participants reviewed, treated, and
managed patients undergoing breast cancer treatment and therefore had a stake in the
assessment of these patients. The questions elicited the opinions of the professional
participants on the different levels of interventions designed for the patients at various
points in the treatment trajectory.
The quantitative part of the study consisted of 100 selected participants who fell
under the inclusion criteria. The formula that was used to verify the minimum sample
size was n = [Z²p (1-p)]/E², where, n = minimum sample size, p = population proportion
of the breast cancer patients available during the time of the study, Z = confidence level
usually defined as 95%, and E = the maximum allowable error (5%). According to the
Department Registry at the Oncology Unit of Ghana, Accra, an average of 140 patients
begin treatment every month. Out of 140 patients, an average of 65 are breast cancer
cases. Hence, within 3 months, a total of 195 patients will typically undergo radiation
treatment. The breast cancer population proportion for the three months was therefore
195/420. Therefore, N = [0.95² (195/420 (1-195/420)]/.05², and the minimum sample size
was N =89.7, approximately 90. Hence, the selected sample size was 100 for the period
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of the study. The close-ended questionnaire was distributed to the selected patients and
collected after completion.
Participant Selection
The selection of the professional participants was from a pool of over 30 staff
with a minimum work experience of 5 years. The reason was that with 5 years’
professional experience, the staff should be able to assess patients thoroughly, manage
treatment symptoms, and perform complete treatment for breast cancer patients.
Recruitment of patients was through the eligibility and exclusion criteria.
The eligibility criteria for the 100 patients were that
•

the patient was diagnosed with breast cancer,

•

the patient was undergoing radiotherapy,

•

the patient was above 18 years of age,

•

the treatment had lasted for a minimum of three weeks, and

•

the patient was mentally competent to answer the questions.

The exclusion criteria were:
•

non resident Ghanaians;

•

poor performance status regarding the stage of the breast cancer and effect on
the participant, such as metastasis to other parts of the body, resulting in an
inability to respond to the questionnaire appropriately; and

•

worse diagnosis where the patient previously diagnosed with a cancer was in
the declining, most severe stages of disease, and the resulting pain would
prevent participation.
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Role of the Researcher
I was an observer, and though I am a radiotherapist, I was not involved in the
treatment of breast cancer patients during the time of the study. I was involved neither in
the review process of the patients nor the simulation of the patients at the date of the
survey. The senior radiotherapists on post at the time of the study selected the patients;
therefore, possibility of researcher bias was significantly minimized.
Data Collection
I collected data for the study using a semi-structured questionnaire that was a
modified version of Patient Health Questionnaire and Depression Anxiety Stress Scale
(Appendix A). Usually, patients scheduled for treatment are called from the waiting room
to the control room to prepare for their treatment. The administration of the questionnaire
took place in the control room where patients are called before to the commencement of
any procedure. Patient demographics such as the age, sex, education, marital status, and
income level were measured and used as independent variables. The period of treatment,
waiting times, type of cancer, and the remedy for the anxiety and depression experienced
were measured as well.
Qualitative data were information from participants collected through the
interviews. The British Educational Research Association (2009), indicated that
interviews are the best way of seeking the views of other people. Open-ended questions
through conversations in a format of mutual understanding occurred among the
participants, allowing them to express themselves (Appendix C). These interviews
encouraged members to share and provide different opinions about anxiety and
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depression as they took care of breast cancer patients. The time for the meetings was 15
minutes for each of the selected participants
Data Management and Analysis
Interview data were analyzed using the NVivo version 11 for Mac by QSR
International through transcribing, finding emerging themes, coding, and making
connections to the research questions. For the quantitative analysis, the hypotheses were
H0: There is no significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
H1: There is a significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
The quantitative data analysis used SPSS version 21 to evaluate the relationships
between the responses of breast cancer patients on their treatment and their level of
anxiety and depression. I performed multiple regression analyses on the quantitative data
as this was appropriate whenever there was a desire for the predictive value of a
correlation between variables (Gravetter & Wallnau, 2013). Responses in frequencies for
the questionnaire were determined and presented in the forms of tables and graphs.
Again, I assessed the normality of the distribution of variables through physical
examination for outliers and the analysis of the skewness and kurtosis for the measures of
anxiety and depression. I again performed multicollinearity to determine depression and
anxiety between the independent variables (age, sex, education, marital status and income
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level). Finally, I conducted a multiple regression analysis to test the hypotheses and the
regression analysis to test for interactions between the variables and anxiety and
depression.
Validity and Reliability
The study did not involve any experiment nor any threats to internal validity. It
was, however, possible that threats to statistical conclusion validity could take place
when the investigator makes insufficient inferences and generalizes the results to the
whole population. Again, I anticipated that with little statistical power, the effect size
being estimated was biased, or the statistical assumptions were violated, or even when the
size of the sample was too small (Marczyk, DeMatteo, & Festinger, 2005). Again, there
is a potential for a little statistical power when the instruments are unreliable and
endangerment of the statistical conclusion validity. However, all the tools selected for the
study were thoroughly reviewed for psychometric adequacy and assessed to evaluate
internal consistency using Cronbach’s coefficient alpha.
Ethical Review
I obtained ethical approval for the study from the Institutional Review Board
(IRB) of Walden University, and all efforts were made to ensure and uphold this. With
adult patients to be selected for the survey, the anticipation was that the risk might be
minimal, protect their identity upholding the Helsinki declaration. However, support
services were readily available for participants in case of any need of any further
clarification about their level of anxiety and depression.
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In this study, the participants involved human beings, and therefore it was
essential to observe ethical principles as indicated by Burkhart & Pawlik, (2017). The
investigator considered the basic principles of ethics during data collection, and this
involved the respect for autonomy, the respect for privacy and confidentiality, the need to
consider a risk of harm, and the need to avoid deceits or exploitation. The use of a
voluntary informed consent in this study indicated the participant’s agreement to
participate in the research with a full understanding of the purpose and implications of the
study. This consent according to Burkhart & Pawlik, (2017) included disclosure,
comprehension, voluntary and competency.
Respect for Autonomy
As indicated earlier on, the investigator sought consent from the participants
(professional and patients) and ensured that participants understood the intent of the study
and were willing to participate. The process of consent for the participants were both
written for the patients, and verbal and written for professionals. Participants could
withdraw from the study at any time without prejudgment.
Respect for Privacy and Confidentiality
Privacy deals with access or information about participants whereas
confidentiality relate to the way the researcher treats information about participants in the
study (Geana, Erba, Krebill, et al., 2017). Lancaster, (2017) indicated in a study that
attaining direct entry to one’s information and personal issues without any knowledge
and approval from them becomes a breach of the individual’s privacy. Lancaster,
however, explained that the breach of confidentiality of the individuals occur when

46

investigators obtain their data or information without their consent. This investigator
considered privacy and confidentiality as a priority in the study and participants were
assured of the high level of privacy. Participation was confidential and voluntary, and it
had no detrimental effect on their overall treatment should any patient decide to
withdraw.
The Need to Consider Risk of Harm
A risk is any prospective harm involving the physiological and psychological
structures such as distress, injury, and loss of self-esteem (Dooley, Slavich, Moreno, &
Bower, 2017). Assurances of protection against any physical discomfort and harm during
the process occurred.
The Need to Avoid Deceit and Exploitation
The investigator explained the purpose of the study to participants to rule out any
form of deceits and exploitations of participants. Granek, Nakash, Cohen, Ben‐David, &
Ariad, (2016) have indicated in their study, that members could make incorrect
assumptions when the explanation of the purpose and the process are incomplete.
The investigator sought approval for this dissertation from the Walden University
IRB before the beginning of data collection and the Oncology Unit of the hospital in
Ghana. Rudestan & Newton, (2015. p. 313) are of the view that for research to be carried
out, the researcher is required to obtain authorization from the IRB at the institution
where the candidate is enrolled and the sites where the research would take place. The
Walden University, therefore, requires that students engaged in dissertation writing
submit their proposals to the IRB for approval before data collection. The submission was
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to ensure that the student complies with the University's ethical standards as well as U.S.
federal regulations (Walden University, n.d). The IRB approved the proposal on July, 6,
2017 (IRB approval no: 06-07-17-0475898). The oncology unit also required that before
any information on a patient undergoing radiation treatment goes out, approval is sought
to protect the privacy of the patient and this was done appropriately.
The investigator would keep the data in a locked cabinet for seven years as
required by the American Psychological. There was a test for all assumptions and
conducted accurately and honestly during data collection, data analysis as well as data
interpretation of the data.
Summary
The investigator used interview and a survey to answer the research questions
using six participants for the interviews whereas 100 patients for the survey. The sample
size for the quantitative study was determined using a power analysis and verified with
power analytic framework (Faul et al., 2007). The minimum number of participants from
the power analysis required for the study was 89.
After these applications, the Walden IRB gave permission to commence with the
study, and followed with data collection. Participants were only permitted to take part in
the study after they had given informed consent and permission. The patient participants
completed the survey while the professional participants signed the consent forms as
proof of their approval. The investigator will keep the consent forms locked to assure
confidentiality. The findings were presented in Chapter 4 representing the results of the
study, both qualitative and quantitative.
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Chapter 4: Results
Introduction
The purpose of this study was to find various interventions for depression and
anxiety among breast cancer patients undergoing radiation treatment in Ghana. The study
explored a combination of qualitative and quantitative data through a concurrent
triangulation involving semi structured interviews with selected professional participants
and a detailed survey. The reason for the choice of the mixed method was to explore
potential causes of anxiety and depression among breast cancer patients and map some
interventions for them. The research questions that guided the study with the hypotheses
are repeated in this section to guide the analysis. The research questions and hypotheses
were:
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing
radiotherapy with high-level anxiety and depression?
RQ2-Quantitative: How does the effect of breast cancer stage, the cost of
treatment, and waiting time affect a patient’s level of anxiety, depression, and
treatment responses?
H0: There is no significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
H1: There is a significant relationship between the responses of breast cancer
patients on their treatment and their level of anxiety and depression and
treatment response.
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In this chapter I summarize the data collection procedure, describes the preparation of the
data for analysis, and provides the results of the analyses.
Data Collection and Management
Data collection began on Thursday, June 8, 2017, at exactly 9:23 am GMT and
ended on July 13, 2017, at 3:12 pm GMT. On the first day of the study, I distributed
seven questionnaires to patients after they consented to participate in the study. The data
collection continued through the whole study until the last patient participant completed
the survey on July 13, 2017. I collected the qualitative data through face-to-face
interviews from June 29, 2017, and on July 4, 2017, in the afternoons, beginning with the
oncology nurses, followed by the radiotherapists, and finally the oncologists.
After data collection, I entered the responses of the questionnaires into SPSS
version 21. I screened the data, scored the instruments and conducted statistical analysis.
As described in Chapter 3, a power analysis using G*Power 3.1.9.2 software and a
minimum sample size calculation were both used to determine the appropriate sample
size for the study (Faul et al., 2007). Both items indicated that a minimum sample size of
89 was required.
Coding Analysis
I recorded the interviews on a phone device, and the audio files were in English. I
listened to each of the recordings a minimum of seven times and documented them on in
a Word document (Appendix E-J). I imported the interview materials into the NVivo
software version 11. I then opened them and explored all six participants, grouped them
into categories such as doctors, nurses, and radiotherapists. Initially, I identified the

50

responses to each interview question and then related them to the research question. I
then coded each transcript using an inductive coding approach from by Thomas (2006) in
which the investigator teases out important themes from raw data.
Themes
I generated the themes as I read and reread the transcripts of the interview
documents. Following this, I carefully analyzed the interviews with the research question
and formed themes including complaints from patients, the cost of treatment, fear of the
unknown, the burden of the disease, spirituality, the need for psychotherapist, and several
others. Some of the coding categories changed after consideration of the data. When I
identified a new code or deleted a code, I went back to the particular transcript to reread
and make the appropriate changes as described by Campbell, Quincy, Osserman &
Pedersen, (2013). I visualized by displaying some of the word on word tree (Figure 8). I
conducted text search for some words to see the frequency of them from the participants.
I did a matrix coding and comparison for some of the items. Finally, I recorded all the
insights drawn from these analyses and used them for the write up of the discussion of the
study.
Research Findings
The following sections present the results of the study. The first section displays
the qualitative data from the NVivo while the other shows the quantitative data from the
SPSS. I further divided these sections into sub sections. There were five subsections for
the qualitative data. These were the participant demographics information such as gender,
profession, and years of practice. The other sub sections display the discussion on
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complaints, solutions prescribed, feedback from patients, and the management. All these
sub sections answered the first research questions. The quantitative data section was
divided into four main sub sections. The first displays socio demographic data, followed
by anxiety and depression about treatment, and interventions for management. This
section answered the second research question.
Qualitative Data
Descriptive Statistics for the Interviews
Table 2 provides the demographics for the responses given by professional
participants. I de-identified the participants using pseudonyms. In all, 33.3% of
participants were females, and 67.7% were males. The results showed that the
oncologists interviewed had the least numbers of years of professional experience.
Table 2
Participant’s Demographics
Gender

Profession

Years of Practice

Male

Doctor (oncologist) (D1)

5-6

Male

Doctor (oncologist) D2)

5-6

Male

Radiotherapist (R1)

9-10

Female

Radiotherapist (R2)

5-6

Female

Nurse (N1)

7-8

Male

Nurse (N2)

7-8
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Research Question
RQ1 was: What are the experiences of breast cancer patients undergoing
radiotherapy with high-level anxiety and depression? The collection of data from the six
participants interviewed answered the research question above. I asked a series of
questions from the three categories of profession chosen (Appendix C). The questions,
though similar, were categorized. To determine what form of management or
interventions patients received for their level of depression and anxiety, I asked the
participants (D1, D2, R1, R2, N1 and N2) about their reviews, treatment sections, and
radiotherapy delivered to patients. Again, discussions on the interventions of depression
and anxiety was discussed thoroughly.
I generated themes from the responses received and read and reread transcripts
several times to make meaning of the responses of the participants. Some the themes that
emerged were (a) complaints from patients, (b) the burden of the disease, (c) waiting
times, (d) interventions prescribed, (e) feedback for patients, and (f) management of
depression and anxiety.
Formation of Themes
Complaints from patients. There were series of questions during the interview
on anxiety and depression. I began by asking participants whether they received
complaints from patients about their level of anxiety and depression. The responses from
all the participants indicated that breast cancer patients undergoing treatment complain.
There were frequent complaints that ran through all three categories of persons
interviewed. The complaints were shared among patients, and some of these were
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distress, the burden of disease, fear of the unknown, waiting time before treatment, and
cost of treatment. Others were also specific to the unit where treatment was ongoing.
However, some of these complaints were profession-dependent, and though the
interview questions were the same for each of the participants, the responses were
different from the individual profession. As shown in Figures 4 and 5, all the doctors saw
the cost of treatment as an indicator of patient anxiety and depression. Again, one the
nurses talked much about cost and expressed how patients are distressed with the large
amount of money needed to pay for treatment, though the other nurse did not. One of the
radiotherapists mentioned cost as an indicator.

54

Figure 4. Participants discussion on patients’ complaints.

55

Figure 5. Participant’s discussion on patients’ complaints on cost of treatment.

The burden of the disease. This was discussed extensively by the participants.
The burden covered the complaints including the high cost of treatment, distress from the
disease as well as the daily treatment, and fear of the unknown as well as experiences
shared by the professionals (Figure 6).
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Figure 6. The burden of the disease.
In trying to understand the burden as related to cost, some of the responses were:
•

Their financial commitment to the treatment is high . . . and the chemotherapy
drugs are very costly . . . and the overall treatment is way too expensive for an
average Ghanaian. This will be too hard for them. (N2)

•

Financial burden of patients affect the information they receive in the clinic.
(D2)

•

Patients also complain of the financial burden as they have to pay their
treatment from the beginning through to the end . . . most of them say they are
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traders and earn very little and therefore the payment is an issue for them.
(D1)
•

The disease is affecting their work, and this is affecting their ability to pay
their treatment cost. (R2)

Participants again expressed distress from the disease as indicators that could
result in anxiety and depression. The investigator identified this as a burden of the
disease, and responses to these were:
•

According to her, she lost her hair, finger nails were burnt, and had several
issues with the drugs, which was distressing for her . . . She expressed
concern, anxious, and didn’t know how long she will live. (N1)

•

Exposing themselves especially to male therapists is a big issue for these
women. (D1)

•

From the information patients provide, staff can tell whether this patient is
in some distress. After the explanations of the side effects, the patient
becomes even worse. (R1)

•

So just seeing machines at the treatment unit is enough to scare them
through their treatment trajectory. (R2)

For fear of the unknown, one of the professionals expressed it this way: “This in
effect increases their anxiety and depression as they are constantly afraid.” (N2) With
their experiences, some also indicated some burden they see on patients. This was how it
was expressed:
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•

She was anxious about the outcome of the treatment, family life, and coping
with work . . . She was concern about the darkening of her skin as a result of
radiation, sore throats, and her ability to go back to work after treatment. (D2)

•

I realized that she was disturbed, and so I decided to talk to her. Money to pay
bill was a problem, the husband was not in talking terms with her because of
the burden of the family, besides they got married not long ago. (D1)

•

She was afraid she was going to get a heart attack because somebody told her
that her heart is close to the area of treatment. (R2)

Waiting times. A text search done on waiting time (Figure 7) revealed that the
participants did not mention nor saw waiting times as major complaint from patients.

Figure 7. Text search on waiting time.
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Interventions Prescribed for Patients
The section of the question was a kind of response to the complaint from patients.
The responses indicated the interventions prescribed, discussed or suggested to patients
undergoing treatment. Grouping them by professions, these were the responses;
•

I try to reassure them of the treatment and counsel them of the fact that the
side effect is not permanent and that once they finish their treatment, it will
end. I try to educate them on the disease and the entire procedure. I encourage
them to go through to the end. (D1)

•

I also prescribe some medications for them sometimes, and some even get
sleeping tablets because they complain of sleep impairment. I give them the
right pieces of information, and when I feel I can’t help, I usually refer to the
appropriate unit. I give assistance in the form of introductory letters on request
from patients to their work places for financial support. (D2)

•

Explaining what the process is all about, and letting them know that, yes, the
machine is big and scary, but this is what it does to treatment. I also inform
them that I am monitoring the while treatment is ongoing and when they talk I
can hear them and see them, so they should not fear. I usually advise them to
do something they love doing to take their minds off all the stress. (R1)

•

I inform them that if they are in any form of distress during treatment, they
should signal me and then I will come to their aid. I usually advise them to get
used to the treatment within a day or two. I also advise them to get relief or
excuse duty from work or even take some days off while’s treatment is

60

ongoing to get enough rest to cope with treatment if that will not cause any
problem for them. (R2)
•

The first stage is the counseling for the patients, I discuss every possible side
effect to patients . . . I personally also try to debunk any negative information
they have heard from people concerning the treatment, like “you will die’,
‘they will cut your breast,' ‘your hair will be gone’ and the likes. (N1)

•

I try to talk to patients often and refer them to the doctors as and when needed.
(N2)

Feedback From Patients
The second question was a follow-up question from the first issue on complaints
from patients. Results from the feedback as expressed by participants are as follows;
•

Patients usually get better and are less apprehensive in their next visit. (D2)

•

They complain of several side effects that make them weaker and more
worried even in their next visit. (N1)

•

We have a positive feedback, for example those with financial burden by their
next visit will be smiling and be cheerful especially when they get support
from people. Again, by their next chemo visit, even if they may have
complaints, they will look more friendly, and open-up. (N2)

•

From their next visit or review, most of them become better and their
confession changes. The anxiety or depression may not be completely gone,
but they will still be positive. (D1)
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•

Most times, I will say it’s almost 90% positive feedback. Those who do not
put their minds to the reassurances we give them, of course, continues to have
issues. (R1)

•

Yes, we do see positive feedback, even from challenging patients if I should
put it that way. (R2)

From a word frequency query run, words like patients, treatment, and anxiety were
outstanding (Figure 8). There were also words like interventions, depression that showed
up boldly.

Figure 8. Word frequency.
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Management of Depression and Anxiety
The management discussed by participants as the interacted with their patients
were; the need for a psychotherapist, or a counselor, spiritualist or a pastor, physical
therapist or exercise, and finally medications.
Psychotherapy. Responses from five out of six participants indicated the need for
a psychotherapist with the Oncology department in Ghana. These were the responses;
•

One thing that I can think of is that you know in most companies or hospitals,
they have Psychologists and Cognitive behavioral therapist who help in the
counseling. (N2)

•

I also believe that oncology department needs a clinical psychologist, it’s
essential because they can see to these patients separately. (D2)

•

I think that we need psychologists to handle these patients. (D1)

•

I think we should get a psychologist. (R1)

•

I think we need a psychologist who will counsel these patients right from the
start of treatment. (R2)

Spiritual. Two participants mention pastors and prayer.
•

I also see pastors in the morning praying with some of the patients and I
believe that also help with those who believe in these. (N1)

•

I talk to them about their spirituality because of what I believe. Of course, we
have variety of patients, some are Christians, Muslims, and other
traditionalists, but I try to let them know that cancer diagnosis is not a death
sentence and that is not the end of the world. (N2)
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Physical therapy. Two of the participants spoke about the need for
physiotherapy.
•

Education on patients should be all round through the treatment and counsel
them to exercise if possible to get some relief. (D1)

•

I encourage them to exercise if they can. (R2)

Pharmacological: One of the doctors mentioned about prescription of drugs for
patients at some point
•

I also prescribe some medications to take care of the anxiety, and depression,
some even get sleeping tablets because their sleep is impaired. (D2)

The Table 9 summarizes all the results discussed in this chapter on the interviews
conducted.
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Figure 9. Summary of participant interviews (N = 6).
Quantitative Data
Descriptive Statistics for Demographics
The Table below provides the socio-demographic characteristics for the responses
given by the 100 patient participants. The age group of 50-59 years had the highest
frequency of 28% whiles the least was 80-89 years. All the participants (n=100) were
females with the Akan tribe with the highest rate of 37%. Those married had the highest
frequency (73%). With the employment status, 51% of the participants were full-time
workers. Forty-one percent were not into any job as well. In all, 89% had no family
history of breast cancer and the majority (55%) had the disease duration of one to three
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years. Finally, 41% of participants had a monthly income of less than a thousand Ghana
Cedis (which is less than 300 USD).
Note. The n’s do not always add up to 100 or a percentage of 100 because some of the
patients decided not to answer some questions.
Table 3
Socio-demographics characteristics
Frequency

Characteristic

Percentage (%)

(n = 100)
Age-group (YRS)

Family history

Tribe

Weight (KG)

Cumulative
percent

20-29

4

30-39

22

4.0

4.0

22.0

26.0

40-49

19

19.0

45.0

50-59

28

28.0

73.0

60-69

17

17.0

90.0

70-79

9

9.0

99.0

80-89

1

1.0

100.0

YES

10

10.0

NO

89

89.0

AKAN

37

37.0

GA-ADANGBE

29

29.0

EWE

19

19.0

NORTHERN

15

15.0

31-50

7

7.0

51-70

36

36.0

71-90

43

43.0

91-110

12

12.0

2

2.0

>110

10.0
99.0

37.0
66.0
85.0
100.0

7.0
43.0
86.0
98.0
100.0

Table continues

66

Characteristic

Frequency

Percentage

(n = 100)
Marital status

Disease duration

(%)

Cumulative
percent

SINGLE

11

11.0

MARRIED

73

73.0

DIVORCED

5

5.0

WIDOWED

11

11.0

< 1 YEAR

13

13.0

B/N 1 &3

55

55.0

YEARS

31

31.0

11.0
84.0
89.0
100.0

13.0
68.0
99.0

> 3 YEARS
Employment

FULL TIME

51

51.0

status

PART TIME

6

6.0

UNEMPLOYE

3

3.0

RETIRED

36

36.0

STUDENT

3

3.0

Monthly income

NIL

41

41.0

(GH)

100-999

21

21.0

1000-1999

27

27.0

2000-2999

5

5.0

3000-3999

3

3.0

51.0
57.0
60.0
96.0
99.0

41.0
62.0
87.0
92.0
3.0

Descriptive Statistics for the Questionnaire
The Table below provides the socio-demographic characteristics of the responses
given by the 100 patient participants. The age group of 50-59 years had the highest
frequency of 28% whiles the least was 80-89 years. All the participants (n=100) were
females with the Akan tribe with the highest rate of 37%. The married had the highest
frequency (73%). With the employment status, 51% of the participants were full-time
workers. Forty-one percent were not into any job as well. In all, 89% had no family
history of breast cancer, and the majority (55%) had the disease duration of one to three
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years. Finally, 41% of participants had a monthly income of less than a thousand Ghana
Cedis (which is less than 300 USD).
Table 4
Descriptive statistics for the questionnaire

Employm

Age
N

Valid

Weight

Tribe

Marital

ent

Monthly

Disease

Family

status

status

income

duration

history

100

100

100

100

99

97

99

99

0

0

0

0

1

3

1

1

3.63

73.60

2.46

2.16

2.33

1.25

2.18

1.92

.139

1.657

.151

.076

.149

.152

.065

.031

4.00

72.00

2.00

2.00

1.00

1.00

2.00

2.00

4

60a

1

2

1

0

2

2

Std. Deviation

1.390

16.567

1.514

.762

1.478

1.493

.645

.309

Variance

1.932

274.465

2.291

.580

2.184

2.230

.416

.095

.117

.429

.586

1.260

.334

1.519

-.187

-2.006

.241

.241

.241

.241

.243

.245

.243

.243

-.728

.089

-1.252

1.642

-1.749

2.645

-.625

6.187

.478

.478

.478

.478

.481

.485

.481

.481

6

84

4

3

4

7

2

2

Missing
Mean
Std. Error of
Mean
Median
Mode

Skewness
Std. Error of
Skewness
Kurtosis
Std. Error of
Kurtosis
Range

a. Multiple modes exist. The smallest value is shown
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Table 5
Bivariate analysis of factors associated with Anxiety and Depression
X2

P

1.02

0.002

Tribe

0.015

0.211

Marital Status

0.375

0.85

Employment Status

0.032

0.914

Monthly Income

1.47

0.5

Disease Duration

9.38

0.136

Family History

0.51

0.78

Characteristics
Age-group

The chi square of the monthly income of patients with anxiety and depression was 1.47,
and the p-value was 0.5. This indicates that income of patients has an effect on anxiety
and depression.
Table 6
Anxiety and Depression on Life Frequencies
Responses
N
Anxiety and Depression on treatment

Total

not at all

Percent
46

5.1%

Occasionally

414

46.1%

quite often

327

36.4%

very often

111

12.4%

898

100.0%

a. Group

With 898 responses on anxiety and depression, 46.1% were occasional and 12.4% were
very often.
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Table 7
Anxiety and Depression on Treatment Frequencies
Responses
N
Anxiety and Depression on life

Percent

not at all

313

17.4%

several days

778

43.3%

more than half the days

556

30.9%

nearly everyday

150

8.3%

1797

100.0%

Total

a. Group

Out of the 1797 responses received from patients on anxiety and depression about their
life while on treatment, 43.3% indicated several days.
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Table 8
Regression Analysis
A. Descriptive Statistics
Mean
Anxiety and depression on

Std. Deviation

N

14.36

4.595

94

Age

51.32

13.641

94

Weight

72.76

16.063

94

Gender

2.00

.000

94

Tribe

2.49

1.515

94

Marital status

2.19

.766

94

Employment status

2.38

1.496

94

Monthly income

1.21

1.502

94

Disease duration

2.22

.658

94

Family history

1.93

.302

94

treatment

B. Model Summaryb

Change Statistics

Model
1
A.

Adjusted R

Std. Error of

R Square

F

Sig. F

R

R Square

Square

the Estimate

Change

Change

df1

df2

Change

.397a

.158

.078

4.412

.158

1.988

8

85

.058

Predictors: (Constant), Family History, Age, Disease Duration, Tribe, Weight, Marital Status, Monthly
Income, Employment Status

B.

Dependent Variable: Anxiety And Depression On Treatment

Table continues
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ANOVAa

B.
Model
1

a.

Sum of Squares

Df

Mean Square

F

Sig.

1.988

.058b

Regression

309.457

8

38.682

Residual

1654.246

85

19.462

Total

1963.702

93

Dependent Variable: Anxiety And Depression On Treatment

b. Predictors: (Constant), Family History, Age, Disease Duration, Tribe, Weight, Marital Status, Monthly
Income, Employment Status

Coefficientsa

C.

95.0%
Unstandardized

Standardized

Confidence

Collinearity

Coefficients

Coefficients

Interval for B

Statistics

Std.
Model

B

1(Constant)

Error

Beta

T

Upper

Toler

Bound

Bound

ance

5.137

Age

-.094

.042

-.280

-2.269

.026

-.177

-.012

.653 1.532

Weight

-.037

.030

-.130

-1.229

.222

-.097

.023

.892 1.121

Tribe

.486

.313

.160

1.554

.124

-.136

1.107

.933 1.072

Marital Status

.940

.635

.157

1.479

.143

-.324

2.203

.884 1.132

Employment Status

-.431

.488

-.140

-.884

.379

-1.400

.538

.393 2.543

Monthly Income

-.923

.443

-.302

-2.081

.040

-1.805

-.041

.472 2.119

.528

.710

.076

.743

.460

-.885

1.940

.957 1.045

-2.403

1.566

-.158

-1.535

.129

-5.515

.710

.937 1.068

Family History

a.

.000 14.009

VIF

24.223

Disease Duration

4.716

Sig.

Lower

34.436

Dependent Variable: Anxiety And Depression On Treatment

Age (B = -0.094, ß =-0.280, t = -0.269, p < 0.05), and monthly income (B = 0.923, ß =-0.302, t =-2.081, p < 0.05) were statistically significant in predicting the
anxiety and depression among the patients as compared to the rest of the variables. The
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beta value for disease duration, marital status, and tribe indicate that anxiety and
depression on treatment increases respectively holding all other variables constant (0.76,
0.157, 0.160) showing a positive relationship. The VIF is less than 3 for all variables,
meaning that there is a positive correlation. Hence, the assumptions are met, and
therefore the conclusion is that the independent variables are not confounding. All other
things equal, these lower levels of VIF, indicate a positive effect on anxiety and
depression associated with a multiple regression analysis.
From Table 8, R (0.397) was found to be less than 0.5, indicating that there is a
change in the model. The alternate hypothesis is therefore accepted since the independent
variables significantly predicted anxiety and depression. An ANOVA was conducted for
anxiety and depression as the dependent factors and demographic as the predictors.
Intervention of Anxiety and Depression
A greater percentage (30.7%) of the patients indicated meditation as their
intervention while few (9.1%) were of the view that their doctors referred them for
counseling (Figure 10).
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INTERVENTION OF ANXIETY AND
DEPRESSION
MY DOCTOR HAS REFERRED
ME TO CBT FOR COUNSELLING
40.40%

28.30%
THERAPIST HAVE ADVICED ME
TO EXERCISE WHEN
DEPRESSED
56.60%

88.90%

I MEDITATE WHEN
DEPRESSED

I PRAY WHEN DEPRESSED

94.90%

I HAVE BEEN ADVICE TO TAKE
MY MEDICATION WHEN
DEPRESSED

Figure 10. Interventions of anxiety and depression, n = 100.
Summary
The chapter presented the results of the findings. The first data was qualitative
with typing the recorded data of the six participants into word and transporting them into
the NVivo. Coding analysis followed by formation of emerging themes, visualization of
results, and finally, recording all insights from analysis into write up. The quantitative
part of the study described the demographics, and I conducted a descriptive statistics. I
performed a bivariate analysis of factors associated with anxiety and depression for the
independent variables. There was also a Regression analysis comprising Anova, and
coefficients of variables such as Age, and monthly income were statistically significant in

74

predicting anxiety and depression. The R (0.397) value was less than 0.5, which depicted
that the alternate hypothesis could be accepted. The independent variables significantly
predicted the Anxiety and depression. Finally, I presented the intervention of anxiety and
depression in a pie chart, and a 30.7% indicated that they meditate whenever they are
either anxious or depressed. Chapter 5 will further discuss and interpret these results of
the findings.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This final chapter is organized into five sections beginning with the introduction.
The overview consists of a short synopsis of the reasons underlying the purpose of the
study, and I review the research questions and discuss the findings. I interpret the results
in the context of the literature reviewed as well as the theoretical framework discussed in
Chapter 2. The study limitations follow along with recommendations for further research
and the implications for social change.
The purpose of this study was to find various interventions for depression and
anxiety among breast cancer patients undergoing radiation treatment in Ghana. In this
study I explored a combination of qualitative and quantitative data through a concurrent
triangulation involving semi structured interview with some selected professional
participants and a detailed survey. Through this study I sought to address a gap in the
literature by identifying significant relationships between the responses of breast cancer
patients undergoing radiotherapy treatment and their various levels of anxiety and
depression, as well as their treatment responses. The research question for the
quantitative study looked into how factors such as stage of cancer at presentation, the cost
of treatment, waiting times, the burden of the disease, and other factors affect the
treatment responses of patients. The qualitative portion of the study focused on the
experiences of the patients with their caregivers as they underwent their treatment.
This study was vital given the scarceness of literature on the subject for Ghana
and Africa at large. As discussed in Chapter 1, a thorough search of literature conducted
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among all the research studies identified only a few focused studies. These were on
assessment of anxiety and depression among breast cancer patients undergoing radiation
treatment (Srivastava et al., 2016; Hassan et al., 2015; Chintamani et al., 2011; Dastan &
Buzlu, 2010; Vahdaninia et al., 2010), and none of these studies took place in Ghana or
even in Africa. The experiences of cancer patients in the African context is different from
those in the developed countries, and there are few studies on African patients. Most of
the patients present with late-stage disease, and therefore the focus should be on how to
manage them. The risk factors associated with anxiety and depression among cancer
patients have been well documented (Yang et al., 2017; Metcalfe et al., 2013; Lin et al.,
2013). Though limited, none of these studies were conducted in Ghana.
Issues that confront patients undergoing treatment in Ghana are different from
what pertains in the Western world. For example, waiting time, cost, and stigmatization
may not be an issue for a patient in the developed countries, but in Ghana, they are major
problems. The literature discussed in Chapter 2 revealed that cancer patients in Ghana
have to pay their cost of treatment because radiotherapy and cancer care are not under the
National Health Insurance Scheme. The trauma of financial inadequacy coupled with
long waiting hours before treatment is worrying. Factors such as age, marital status,
occupation, total monthly income, and tribe play a critical role in determining the level of
depression and anxiety. A common item noted in this study was the fact that any cancer
diagnosis could be a very stressful experience for the patient as well as their family as a
whole. These experiences coupled with the several issues associated with the diagnosis
such as late presentation, treatment, and survival could pose significant uncertainty for
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these patients from the onset of diagnosis (Kim, Carver, Spiegel, Mitchell, & Cannady,
2017).
Interpretation of the Findings
Description of the Interviews
Following RQ1, I examined the experiences of breast cancer patients undergoing
treatment on their levels of anxiety and depression. The data were from semi structured
interviews with six participants, two male oncologists with 5-6 years of experience, two
nurses (a male and a female) with 7-8 years of practice, and two radiotherapists (a male
and female) with 9-10 years and 5-6 years of experience respectively. The experiences of
patients as reported by the participants cut across cost of treatment, the burden of the
disease causing distress in patients, and interventions prescribed.
Cost of treatment. The results indicated that professional participants received
complaints from patients especially on distress, the burden of the disease on their life,
fear of the unknown, cost of the treatment and their waiting times (Figures 5, 6, and 7).
According to the participants, the burden of the disease resulted from the high financial
commitment from patients which is one of the indicators of anxiety and depression.
Treatment cost of breast cancer ranges between $1,000 - $2,000 and the reports from the
study indicated that such money was too high for average patient. According to the
participants, this affects the information patients received in the clinic during the review
and their overall output. Again, the overall treatment cost could be much higher when
chemotherapy and hormonal therapy are prescribed. These findings were in agreement
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with the study by Opoku et al., (2012) which indicated that financial burden could
significantly affect the overall treatment outcome for patients undergoing treatment.
Responses from the participants (Figure 5) indicated what transpires in the
oncology setting in Ghana. Doctors usually acquire the consent before the start of
treatment, which includes discussion on the cost of treatment. This process may explain
why both doctors mentioned cost as an indicator of depression and anxiety. Some
therapists and nurses at some point spend time during treatment to further remind patients
to pay their bills, though this is not mandatory for them to do. This reason may explain
why some mentioned cast in the interviews and others did not. In the oncology setting in
Ghana, only doctors are mandated to bill, prepare, and ask patients about their treatment
bills.
On the whole, all the participants who mentioned cost from their interactions with
the patients indicated a high level of pain and trauma resulting from the high cost of
treatment of breast cancer in Ghana. According to the participants, this burden leads to
elevated levels of anxiety and depression expressed at different points during their
treatment regime. These findings were in line with a study by Opoku et al., (2012) that
indicated patients’ displeasure on the high cost of treatment. Though according to
Ginsberg et al. (2012) literature on the cost of breast cancer treatment is mostly
emphasized in the high-income countries, this study showed that cost of treatment is high
in a middle-income country such as Ghana. A suggestion made by Zelle et al., (2012)
identified cost-effectiveness analysis as an agent that could help intervene in the cost of
treatment of breast cancer.
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In an interview by a popular press firm with an oncologist in Ghana on the cost of
cancer, Dr. Aryeetey indicated worries about the burden patients go through in the
payment of their bills (Graphic online, 2015). Dr. Aryeetey expressed observations about
the high cost of cancer treatment and how it places a burden on many patients, some of
whom are unable to pay their medical bills. Dr. Aryeetey indicated that many cancer
patients had abandoned their treatment as a result of the high cost of treatment,
suggesting that a national cancer fund should be established to contribute towards the
treatment of cancer in the country to lessen the financial burden on patients. Dr. Aryeetey
also noted that due to the high cost of treatment, persons diagnosed with breast cancer
may delay in seeking treatment, reporting later with advanced stages of the disease, when
very little can be done to promote their survival.
In another press communication (Financial Times, 2013), a parent expressed
worries and pointed out that families in Ghana struggled to meet the cost of cancer care
and pleaded with the government to meet them halfway if possible. He said all his family
savings had been spent on the treatment, and they had no money left to feed the rest at
home, resorting to prayer camps for a solution.
Burden of the disease. As shown in to the Figure 6, the interviews indicated that
the burden of the disease was the subject of some complaints from the patients under
treatment. The constitution of the burden included financial commitment, worry about
whether they will be able to complete treatment because of an inability to pay. Another
burden that led to distress was the loss of hair, discolored finger nails, and various issues
with cytotoxic drugs. Hair loss (alopecia), because it is visible to others, can cause
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considerable distress for patients (Boehmke, & Dickerson, 2005). The crown of hair is
part of the patient’s self-image and can affect the patient’s confidence as well as the way
they see themselves (Helms, O'Hea, & Corso, 2008).
One of the patients expressed her concerns to one of the participants (N1) about
how upset she was after her hair loss, though she was counseled about it. According to
Sheppard, & Ely, (2008), losing their hair could be associated feelings of with loss of
sexuality and desirability by the patients. A recommended solution suggested by the
Breast Cancer Network Australia (2011) was that patients have to be prepared thoroughly
by the caregiver before the treatment, and individual patients should talk about it with
others such as family and friends. This will help patients adjust to their temporary change
in appearance. Breast Cancer Network Australia also suggested that patients discuss this
change with their children to prepare them for it, assuring them that their hair will grow
back.
On the issue of disfigured and darkening of their fingers and nail beds, N1 spoke
about it as a complaint from patients, adding that counseling and consent before
chemotherapy should include this information. Counseling should be provided for the
patient regarding the changes to fingernails and toenails, pointing out that it is common
with chemotherapy and assuring the patient that it usually fades a few months after
treatment. This education could help patients cope with the changes that occur. Some of
the drugs that cause nail changes include docetaxel, paclitaxel, Adriamycin,
Cyclophosphamide, and 5-Fluorouracil (5FU), among others, and this should be made
known to patients undergoing treatment (Canadian Cancer Society, 2017).
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Participant N1 mentioned issues that impacted on the life of patients undergoing
treatment. For example, participant N1 indicated that patient complaints included
problems with some of the chemotherapy drugs. According to the Cytotoxic Safety
Council (n,d), about 27 chemotherapy drugs are expelled from patients at high
concentrations, and these could cause severe and irreversible illnesses. Some of these
damage deoxyribonucleic acid (DNA), resulting in cell death and affecting the growth
and the development of an embryo, leading to fetal death or defects.
According to N1, other issues were that patients were anxious about the outcome
of treatment, family life, and ability to cope with work after treatment. These were all
vital issues that confronted patients undergoing treatment. One other concern in the form
of a complaint was sore throats as a consequence of the treatment. Patients indicated to
D1 their inability to swallow properly as a result of the treatment. This complaint should
have been discussed in the counseling session for patients before the commencement of
the treatment. The staging of breast cancer is based on the TNM model, where T stands
for size, N is for nodal involvement, and M represents metastasis or spread. Any nodal
involvement will require treatment of the neck and therefore could lead to a sore throat.
Proper technique of set-up for patients and counseling before the treatment could
significantly reduce this. Patients should be advised to remain in the same position for
treatment and cautioned that any movement of the neck while undergoing treatment could
result in sore throat. Counseling of patients should include the management of sore
throat, which is gargling salt water regularly, staying hydrated, and drinking warm water
with lemon (BreastCancer.Org, 2017).
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Another report from one of the participants was the treatment related fear
exhibited by patients. According to N1, a patient was told by another patient that she
would develop cardiac disease secondary to radiation therapy. This information, even
though not accurate, led to fear, which led to depression and anxiety. Treatment of the
breast and lymphatic drainage will undoubtedly involve some vital organs such as lung
and heart. However, the treatment plan with proper calculation of the doses demonstrates
how much each organ within the treated field is receiving and ensures that reference
tolerance levels of each organ at risk is respected (Lawrence, Ten Haken, & Giaccia,
2008). All these will have to be communicated properly to patients during counseling and
consent to avoid situations and comments from patients such as these.
On the waiting time of patients, only one participant (R1) mentioned about some
complaint about their waiting time from a patient, which in effect led to anxiety. Almost
all the participants said nothing about waiting time. This finding were inconsistent with a
study by Kyei & Engel-Hills, (2011) in the same department of the hospital which
revealed patients were delayed at every point in their treatment, affecting the flow of
work in the department. The reason given for this was the increasing responsibilities of
the few Radiation Therapist in the country, as well as the workload of doctors. Currently,
there has been some improvement in human resource, and adopting appointments based
treatment schedule and shifts schedule for treating patients possibly may have reduced
patient waiting time as reflected in the study.
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Interventions prescribed for patients and their feedback
These were various intercessions made by the professional participants for
patients whiles they were on treatment. These were reassurances, explanations of the
entire treatments and side effects, and counseling. Other interventions were
encouragement, advice (such as doing something they love doing, get relief from work,
and relaxation), monitoring, coping, debunking any negative pieces of information from
them, prescriptions for medications, and on few occasions, referring to counsellors
outside the department. All these interventions prescribed to patients the participants
were consistent with literature studies by Zelle et al., (2012) as well as Guo, Tan, Li et
al., (2013). In Table 1, some of the interventions suggested by Zelle et al., (2012) were
supportive care and psychosocial care. Guo et al., (2013) also mentioned medication to
patients who were undergoing several levels of anxiety and depression.
Feedback from patients according to participants were mostly generally positive
except in few instances. According to participants, patients get better and are less
apprehensive to their treatment. Some of the participants indicated that some come with
smiles on their subsequent visit and are more cheerful, friendly and open-up to talk more.
Another negative comment from patients as reported by the participants was feeling
fatigued after treatment, and more apprehensive after explanations. According to this
study, patients become less anxious when they know what is wrong with them, how
treatment will be delivered when proper explanations on the side effects is given and the
more importantly what to do as and when an issue arises. The level of anxiety
experienced by one patient with breast cancer may, however, differ from another patient
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and that may probably explain why others had negative feedback. This finding was
consistent with a literature study by Mura et al., (2012) that indicated reports of pain,
weakness, and more apprehensiveness after patients received explanations for treatments.
Management of Anxiety and Depression
The interactions with participants ended with the way forward for patients, and
this focused on the management of anxiety and depression for patients undergoing breast
cancer treatment. The interventions were mentioned as management were the need for
psychologists, spiritual, pharmacological, and physical.
Psychologists. Almost all the participants indicated the urgent need of
psychotherapist which will mediate as a counselor for the patients and the Oncology unit.
There was a cognitive behavioral therapist who in a way falls under psychology. This
result is consistent with findings discussed in the literature, such as ADAA, (2016).
Again, management of anxiety and depression psychologically offer some benefit to
patients on treatment. A psychotherapist of a behavioral therapist can assist patients by
decreasing the distress associated with disease, thereby improving the quality of life
through continuous counseling (Jacobsen & Jim, 2008). The oncology department will
need this services even if on a part-time basis. The involvement of a psychologist could
help reduce depression and anxiety with the study center. The study of Jacobsen & Jim,
(2008) recommended some psychosocial evidenced-based interventions for the
management of anxiety and depression. The researcher is buttressing on some of them
that will be applicable in Ghana for staff and patients. These are relaxation techniques
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with or without educational training, psycho-education, couples counseling for married
patients, supportive expression therapy as well as cognitive-behavioral therapy.
Relaxation techniques. This method helps patients to relax, attaining a state of
calmness, thereby reducing anxiety or depression.
Psycho-education. This is an evidenced-based therapeutic intervention where
information and support in the form of education are provided to patients to help them
understand and cope with their disease.
Couples counseling. This is a form of helping the couples recognize and accept
the situation at hand, and improving their relationship in the way of supporting each
through the trajectory.
Supportive expression therapy. This is a short term psychodynamic treatment
aimed at a variety of diseases such as depression, anxiety and much more. The goal of
this treatment is to underpin the patient’s healthy and adaptive patterns of thought
behaviors, thereby reducing the effect on the body.
Cognitive-behavioral therapy. It is a goal-oriented psychotherapy treatment that
looks at the practical approach to managing problems through the change pattern of
thinking or behavior.
Spiritual. Two of the participants (33.3%) mentioned prayers as management,
and surprisingly they were all nurses. According to Stranahan (2001), nursing is the
ability to make someone feel physically comfortable by various means. Maddox (2001),
also explained it as the capacity to develop the body's ability to achieve or maintain
health. The perception on the ground is that patients are usually more comfortable talking
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to nurses within the practice than any other profession, which may have perhaps led to
this. A study by Oh & Kim (2014), concluded that spirituality is related to improved
quality of life, and as well reduce anxiety and depression in patients undergoing
treatment. According to them, spiritual interventions confirmed significant statistical
effects on depression in patients with cancer.
Physical Therapy. One doctor and a therapist mentioned the need for exercise as
a form of management of anxiety and depression for patients undergoing treatment, this
according to one of the doctors (D2) could help the get some relief. The finding was
consistent with the study by Stewart & Wild (2016) that mentioned exercise as a benefit
in helping reduce depression and anxiety in cancer patients. Danielsson et al., (2013) also
suggested exercise as a way of improving depressive symptoms.
Pharmacological. Among all the participants, only one (D1) cited prescription of
medication to patients. This result was not out of order for a place like the study site
because, in Ghana, only doctors are allowed by law to prescribe medicines to patients.
This finding probably explains why no other person apart from a physician mentioned the
need for medication. Medications according to Farach et al., (2012), could be used for the
management of depression and anxiety, though the study concluded that the effectiveness
and duration of treatment have not improved in most cases. According to studies by Pirl,
(2004), there are 13 randomized controlled trials of medications of depressive symptoms
for cancer patients including breast. Out of this, eleven are for primary treatment on
depressive symptoms; only one was a pain symptoms, all the rest were for prevention.
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From all indication, this will not be enough for cancer in general, looking at the various
types of cancer worldwide.
Interpretation of the Survey
In research question 2, the investigator looked at how the effect of breast cancer,
cost and waiting time affected patient’s responses to treatment as well as their anxiety
and depression level. There were evaluations of the demographic variables such as
marital status, age, education, ethnicity, among others in multivariate models (Table 3). A
survey of 100 patient respondents between the ages of 20 and 89 years completed and
returned the questionnaire. Eighty Nine percent had no family history of breast, and 43%
were between the 71-90kg of weight. Though 51% of the patients were working full time,
it did not reflect their salary or money earned in a month because 41% indicated NIL for
monthly, perhaps were retired, student and unemployed (36%, 3%, 3%).
With the family history, 89% had no history of breast cancer though diagnosed
with the disease at the time of the study. This was consistent with studies as reported by
ACS, (2013). According to ACS, between 5-10% of all breast cancer is inherited from
parents and family members. Other studies also mention that women with close relatives
to breast cancer patients have a higher risk of developing breast cancer (Shiyanbola,
Arao, Miglioretti, et al., 2017). Another factor that doubles the risk of getting breast
cancer is having one first-degree female relative such as mother, sister or daughter (Ja
Kim, Jung, Eliassen, Chen, Willett, & Cho, 2017). In some instances, breast cancer is
linked to having an abnormal gene such as BRCA 1, BRCA 2 and CHEK 2 (Ahern,
Sprague, Bissell, et al., 2017).
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The result highlighted 37% of the patients as Akan, followed by the GA’s (29%).
The Akan population is the largest in Ghana comprising of the Fante, Asante, Akuapem,
Akwamu, and Akyem, Agona, Kwahu, Wassa, and Bono. This results, therefore, explains
the high percentage by the Akans. From the study of Montazeri, Jarvandi, Haghighat, et
al., (2000), a patient usually show a different need for support with various ethnic
background. This results could, however, be generalized to the overall breast cancer
patients population who present for treatment in Ghana.
With the majority of the patient (79%) within weight of 51-90 kg, it was
indicative that most of the patients undergoing treatment were not overweight, nor obese.
Usually, managing overweight and obese patients with breast cancer could be very
challenging, in particular with the treatment technique of tangential fields. The treatment
of breast which is usually tangential is to avoid treating the lungs and the heart within the
chest region. However, with the tangential fields, the challenge with obese patients is the
treatment of more breast folds within the axilla. According to the CDC reports in 2014,
about 69% of all American adults are overweight, and this increases the risk of women in
that category after menopause of developing breast cancer. The female hormone called
estrogen usually support the growth of breast cancer. This estrogen often comes from
fatty tissues, especially after menopause. Hence, an increased estrogen level enhances the
chance of getting breast cancer. By implication, Ghana is slightly lower compared to
some developed countries like America, to the risk of developing of developing breast
cancer.
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The link between weight and breast cancer risk which will result in anxiety and
depression in patients is usually intricate. Studies have shown that risk increases for
women who gain weight as an adult even though the same risk may not increase among
those who have been overweight since childhood (American Cancer Society (ACS),
2014). Though established that gaining overweight and obesity increases one’s risk, there
is no clear indication whether losing weight reduces a risk. In Ghana, a culture like the
Akan, frown on overweight and obesity though results showed more patients with breast
cancer as Akan (Table 3). There are also some cultures in Ghana like the GAADANGBE that see overweight and obesity as healthy living and evidence of wealthy
living. In a study by Teras, (2012), the central question was whether overweight causes
breast cancer. The author further indicated that women who lost weight and maintained it
for over four years after menopause had a 40% lower risk of breast cancer.
Reports from both the World Cancer Research and the International Agency for
Research on Cancer Fund indicate that there is a substantial indication that being obese or
overweight causes breast cancer after menopause. Another study, by the ACS, 2014,
found out that loss of weight was associated with about 83% lower risk of breast cancer.
It is therefore essential that patient with overweight and obesity tries to lose weight as
much as possible to improve their overall health (Teras, 2012). Although the relationship
between breast cancer risk and weight loss is still under investigation, one of the key
factor is that women can control that body weight.
In the study, 73% of the patient participants were married, and 11% were
widowed (Table 6). According to the results, 83% were indicated their anxiety and
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depression with treatment (Table 7). In a study by Vahdaninia, Omidvari, & Montazeri,
(2010), it was identified that being single was a protective factor for developing
psychological distress while the widowed showed a greater risk. This findings was
however not the case in this study because 83% of the patient population indicated levels
of anxiety and depression though 73% of them were married. Again, marital status was
associated with quality of life in a study by Parker, Baile, Moor, & Cohen, (2003) and
patients with more family support reported less anxiety and depression. Contrary to the
findings of Parker, et al., (2003), Hassan et al., (2015) was of the view that married
women go through many levels of anxiety and depression because of family life and
other dependents to take care. Again, Hassan was of view that single women may be
scared of losing their partners and friends due to their loss of femininity attraction.
The disease duration shown in Table 3, revealed that only 13% of the participants
presented within a year, but 55% were between the 1-3 years. This finding confirms late
presentation of breast cancer in Ghana as reported by several studies (Opoku et al., 2012;
Anderson et al., 2011; Clegg-Lamptey & Hodasi, 2007). Although the study did not find
out reasons for late reporting on the side of the patients, the average duration of
symptoms of more than a year is disturbing. This finding is similar to what was reported
from the same hospital five years ago, indicating no effect of breast awareness programs
because of the patient resort to herbal medications (Clegg-Lamptey & Hodasi, 2007).
Most of the patients who presented after three years had probably reported previous and
defaulted, likely to try an alternative treatment.
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Anxiety and Depression in Daily Life of Patients.
Almost 95% of patients with breast cancer had anxiety and depression in different
categories ranging from occasionally, quite and very often (Table 6). This result is very
high compared to studies conducted Baqutayan, (2012) and Hassan et al., (2015). There
can be some reasons for this differences in prevalence rate. The first explanation could be
the late stage of presentation, the high cost of treatment, lack of financial support, lack of
NHIS, inadequate family support, family dejections, ignoring by spouses, separation,
divorce, fear, and the fact that some think it is communicable. There are other factors like
the way of presentation of breast cancer in the African context, such as witchcraft, juju,
and curse. Others resort to prayer camps, and there is various misinformation by spiritual
leaders which leads to delay in presentation and then causes depression upon treatment.
There is a link between late presentation of breast cancer and awareness creation
of the disease. In a study conducted by Clegg-Lamptey & Hodasi, (2007) about 60% of
the breast cancer patients in Ghana reported with Stage III and IV disease within a
duration of 8 to 10 months. This finding, according to Brewster, Thomson, Hole, Black,
Stroner, & Gillis, (2001) is similar to the presentations within the developing countries
and in Black American women. In Ghana, the duration between the detection of a breast
cancer and presentation of clients to a hospital for treatment is usually long, and this was
consistent with the findings of this study. Delay in treatment is common within the
African context due to several reasons.
The term delay was defined by Harirchi, Ghaemmaghami, Karbakhsh, Moghimi,
& Mazaherie, (2005) as the duration (two weeks or more) before visiting the hospital.
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Other studies by Arndt, Sturmer, Stegmaier, Ziegler, Dhom, & Brenner, (2002) defined
delay as the duration between a month to three between symptom recognition and
seeking treatment. In contrast, Stapleton, Mullan, Dey, et al., (2011) was of the view that
delay deals with the stage of the disease presentation.
Therefore, addressing the causes of this delayed presentation is probably essential
than the promotion of early detection within the country. Usually, the worry is not only
late presentation by patients, but also absconding of breast cancer treatment. Studies
show that within the study site, almost 13% of breast cancer patients abscond after
treatment has commenced (Clegg-Lamptey, Dakubo, & Attobra, 2009). The effect of this
is more advanced stages, inoperable and incurable after these absconders later return.
Reasons for late reporting by patients according to studies were the lack of
specialist within the country, ignorance on the side of patients, fear of mastectomy
(Clegg-Lamptey et al., 2009; Elmore, Armstrong, Lehman, & Fletcher, 2005). Others
reasons from the studies were herbal treatment, prayers and prayer camps, financial
incapacity on the side of the patients, the fear of diagnosis, and resorting to food
supplement by patients. Other reasons for absconding treatment by patients were fear of
mastectomy, side effects of the chemotherapy, faith in their God among others.
Screening for breast cancer has, however, lead to an early diagnosis of breast
cancer and a reduction in mortality among patients (Elmore et al., 2005). In Ghana, no
organized nationwide screening program involves mammography to women at risk of
breast cancer. Although some non-governmental organizations (NGOs), individual
survivals, and other well-meaning groups try to organize breast cancer awareness
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seminars, talks, and conferences to educate women in this regard (Clegg-Lamptey et al.,
2009). Though programs to stimulate early detection may not yield much of the desired
goal because of the human resource available currently, it is essential to realizing early
diagnosis in Ghana to help curb late presentations. In the developed countries many
breast cancers are recognized by the patients, and that helps with early presentation.
Hence, education of what to look out for and self-breast examination will also be crucial
in helping avoid late presentation (DeSantis, Ma, Bryan, & Jemal, 2014). When diagnosis
is made, education for patients could significantly reduce patients’ level of anxiety and
depression.
Fear as defined in a study by Donkor, Lathlean, Wiafe, Vanderpuye, Fenlon,
Yarney, & Kyei, (2016) is an inimitable expressive state of a person which is a prompt
response to a danger or any threat. According to Abdel-Wahab, Bourque, Pynda et al.,
(2013), fear is described by the wish to escape. In most developing countries, the disease
is characterized by fear due to the nature of the disease, mortality rate, and the attribute
that is witchcraft and death. The diagnosis of breast cancer, therefore, trigger different
forms of fear, affecting the presentation of treatment and leads to anxiety and depression
even when they present in Ghana. The possible reason is the fact that breast cancer
education, survivor and support groups barely exist. Again, awareness creation is not
universal, and breast survivals fail to come out publicly and share their experience for
fear of mortification as well as stigmatizations.
Several studies have recognized the use of alternative medicine as a reason for the
delay of breast cancer patients, and late presentation which in effect leads to anxiety and
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depression (Ermiah, Abdalla, Buhmeida, Larbesh, Pyrhönen, & Collan, 2012; Ibrahim, &
Oludara, 2012; Otieno, Micheni, Kimende, & Mutai, 2010 Ukwenya, Yusufu, Nmadu,
Garba, & Ahmed, 2008). In the studies by Ermiah et al., (2012) and Otieno et al., (2012)
the two categories of alternative medicine that were identified to be common within the
African context, where the locally based and foreign based therapies. Local based
comprised of spiritual, prayer, traditional healer as well as herbal treatment. That of the
external support were acupuncture, homoeopathy, and Chinese medicine.
Donkor et al., (2016) explains that the personal belief of patients was highly
related to their using alternative medicine and therefore, the cultural model of every
patient was essential. According to Stephens, Fryberg, & Markus, (2012), the cultural
model any disease is defined as the cognitive model which postulates that seeking health
care is prejudiced by cultural perceptions of the cause of that disease, the management as
well as the coping behavior to eradicate the disease. In Africa, and Ghana, in particular,
many cultures associate cancer with mystical beliefs and symptoms of disease are
ascribed to a curse, bewitching, God or god’s punishment due to personal or family
atrocity or demons. These cultures can be very demoralizing to patients causing severe
anxiety and depression on patients (Opoku et al., 2012). Their belief in the line of this
makes it difficult to manage with contemporary medicine such as such as surgery,
chemotherapy or/and radiotherapy will only worsen the condition. As a result of these,
many Ghanaians rely on their faith, sorcerers, witch doctors, herbalists,
priests/priestesses, pastors, and other spiritualists to treat cancer.
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Anxiety and Depression of Patients on Treatment.
In this study, out of the 1, 797 responses from patients about 83% of them had
depression and anxiety in different categories ranging from occasionally, quite and very
often (Table 7). In Table 8B, the F value was 0.058, which indicated that the null
hypothesis could be rejected and the alternate accepted. In this case, the conclusion is that
there is a significant relationship between the responses of breast cancer patients and their
level of anxiety and depression as well as treatment responses. The finding was consistent
with other studies in Iran that showed 47.2%, and 57% of anxiety and depression
respectively, though the percentage is very high in Ghana (Jadoon et al., 2010). Other
studies in Pakistan also showed similar trends with 52%, 62% on anxiety and depression
respectively (Jadoon et al., 2010). As explained earlier in the literature, the high
prevalence of over 80% in Ghana could be patients’ fear of death in the course of
treatment, loss of hair during treatment, and their inability to get pregnant after treatment.
Interventions for Anxiety and Depression.
According to the responses from the patients, in Figure 10, there is very little
information on Cognitive Behavioral Therapist to help them cope with the treatment. As
a result of this many of the responses indicated that patients resort to meditation and
prayers for management. This findings has been discussed thoroughly earlier. Medication
was also not seen as a regular form of management, though some patients mentioned it.
However, physical therapy was indicated by 18.3% of the patients undergoing treatment.
The findings were inconsistent with studies in the developed where interventions such as
psychosocial and other interventional supports helped cancer patients in adjusting to their
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diagnosis and treatment (Mustian, Alfano, Heckler, et al., 2017). An example was in a
study by Guo et al., (2013) where psychosocial interventions supported patients by
decreasing their psychological distress associated with cancer and improving their quality
of life. Another study also indicated that Psychosocial and pharmacologic interventions
offer some benefit on treatment for depressive symptoms with cancer patients (Baucom,
Porter, Kirby, Gremore, & Keefe, 2006).
Regarding prayer, when individuals are faced with difficulties, comprising severe
and life-threatening conditions such as cancer, they turn towards a higher power or
religion as a way of coping (Thune-Boyle, Stygall, Keshtgar, & Newman, 2006). There
have been works on the effects of religious/spiritual coping in cancer and the differences
in these studies are in terms of methodology, and stages of disease (Nia, Sharif,
Goudarzian, Allen, Jamali, & Gorji, 2017; Lewis, Maltby, & Day, 2005; Abernethy,
Chang, Seidlitz, Evinger, & Duberstein, 2002). However, the results consistently show
the importance of religiosity and spirituality in coping with a cancer diagnosis. Some
other studies have found religiosity and frequent religious attendance to be protective
factors against cancer (Mytko & Knight, 1999).
Other studies also highlighted the benefits of religious commitment which is
affiliated with a particular church, rate of worship attendance as well as beliefs and
concluded that these were associated with low level of anxiety (Ano & Vasconcelles,
2005). There has also been a significant bearing of religious coping in cancer patients on
quality of life, and this has received prodigious consideration suggesting improvements in
the quality of life of individuals committing to religion to cope with cancer (Tarakeshwar,
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Vanderwerker, Paulk, Pearce, Kasl, & Prigerson, 2006). Daaleman & Vandecreek, (2000)
were of the view that coping with breast cancer religiously, provides a sense of drive and
a context for the thoughtful experience of the disease even when it is advanced.
Integration of Data
This final stage of integration of quantitative and qualitative data through
triangulation was used to understand further the entire literature and the findings of the
staff and patients undergoing treatment. As was discussed in the methodology, the study
used a combination of qualitative and quantitative data through a concurrent triangulation
involving an interview with some selected professional participants and a detailed survey.
The triangulation method was to show how the interviews support, confirms or
disconfirm the responses from the patient participants.
The interviews with the professionals did support the responses from the patient
participants. This support were in three sections on the experiences of breast cancer
patients undergoing and how it affected breast cancer patients undergoing treatment. The
first was on the cost of treatment which was discussed thoroughly by the professionals.
This cost on the treatment supported the several complaints of patients due to the high
cost of treatment and their inability to pay treatment because of the kind of job they do.
This same cost, in turn, led to anxiety and depression on the side of patients. The second
was on the burden of disease discussed by the participants which covered a variety of
issues including waiting times. The final section looked at the interventions and
management where the professional participants discussed what they do for patients to
cope with anxiety and depression such as prescription of medications, and referral to a
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psychologist. Other interventions practiced in Ghana by many patients that did not show
up clearly in the study within the oncology setting was physical therapy, and spiritual.
The patient also discussed management though they mentioned meditation, and prayer as
their highest form of managing anxiety and depression.
Theoretical Framework and Research Findings
The theoretical basis for this study buttressed the inputs provided in the survey
that informs preventive or coping for patients undergoing anxiety and depression. This
model was used to describe breast cancer treatment processes from the onset of the
diagnosis, through treatment and the aftermath of treatment. The theory was again used to
predict factors that lead to anxiety and depression both from patients and professionals.
Finally, this theory was used to explain the management or coping with breast cancer
within the context of the setting of the study. The findings of this study suggested a high
level of anxiety and depression among breast cancer patients undergoing radiotherapy.
The interventions mentioned by the patients showed less of cognitive behavioral
therapists or psychologists, but the involvement of prayer, and meditation by the patients
themselves.
The framework HAPA outlined motivational and volitional concepts used in the
explanation and the prediction of individual changes in health behaviors among breast
cancer management. The self-value of patients undergoing treatment was essential in the
responses they gave on their depression and anxiety level. The motivational phase which
dealt with issues of the risk awareness of patients were in two sections. The first, looked
into patients’ level of information about their diagnosis and the second was of their
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responses. These two points were seen to have caused an increased in the anxiety and
depression of patients undergoing treatment as reported by some of the professional
participants. A concern to the researcher was the effect would occur on their level of
survival and cope with treatment.
In the volitional stage, an intention to change a health behavior was needed, and
such change as discussed with both patients and staff participants in the results sections
was the need to strengthen the interventions necessary for these coping process. This
intervention according to Schwarzer, (2008) must be planned, introduced, and sustained
within the oncology setting, and as well, making plans to adjust, manage and
accommodate any relapses that may occur during the process.
Limitations of the Study
One of the limitations among the issues identified was the recruitment of patient’s
participants for the quantitative study. Some of these patients were undergoing chemoradiation and therefore required that the researcher include them in the study. This did not
allow data collection only patients undergoing radiation treatment. The researcher
however, recruited patients directly from the treatment floor, where the participants start
the treatment.
Another limitation of the study which was discussed in the introduction was the
language barrier since not all the members spoke, read or wrote in English. Although,
plans were put in place for translation into the local language where the need arose, there
was no systematic means to determine if the patient participants were in any way
influenced by the investigator.
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Additionally, the timeframe of when participants' answered the questionnaires,
was not under the control of the researcher although an average time of 15 minutes was
allocated for this. This may have influenced the responses from both the professionals
and patients as several conditions could result in the description for the results/responses
obtained.
Finally, since the study was limited to data on patient’s socio-demographics level
of anxiety and depression, other potential concepts of perceived anxiety and depression
such as diagnosis, prior mental issues, and patients’ medications were not reconnoitered.
Unknown is whether, these variable constructs could have affected the study if explored.
Implication for Social Change
This study is imperious to promoting the scholarly research concerning the
complete translation of the coping strategies in handling anxiety and depression. It is,
therefore, crucial to improving on these numerous interventions and strategies that
manage or cope with anxiety and depression, afore, through and after treatment. These
supports will assist patients to deal with issues that confront them when undergoing
treatment. Professionals have discussed thoroughly the issues confronting patients, and in
turn, patients have voiced out their burden as they go through treatment. The researcher
has outlined suggestions and coping mechanisms as a way of solutions throughout the
discussion. The effect of the applications of these approbations will result in a social
change from the study.
On the side of the professionals, it is essential that every multidisciplinary team
member within the Oncology team ensures that efforts are put in place to identify and
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capture the coping mechanisms of every individual patient. Having in mind that every
patient should be treated in a particular way because they cope differently with the
burden of breast cancer, will help put in place support systems to assist, and inspire them.
Again, there should be motivation for patients in helping them to develop coping skills
needed to bear the psychological, financial, emotional, and the physical pain of the
treatment.
Family members could be a source of strength to patients serving to improve the
survival of patients even with the late diagnosis. Relatives and loved ones can be of help
in assisting patients to discover working strategies to cope or manage their depression
and anxiety. Reassurance, showing of affection, care and expression of concern for these
patients will help them meet these burdens from the treatment, and their respective side
effects. Again, educational supports could help patients who can read to a better deal and
cope with the burden of the disease. Doctors and nurses should again bear in mind the
possible addiction of drugs, and should cogitate non-pharmacological remedies to lessen
the debilitating effects of this anxiety and depression (Koob, 2006).
The study’s implications will contribute to wider society and cause positive
change when all stakeholders (caregivers, multidisciplinary team, the ministry of health,
Ghana health service, and the Government) take on responsibilities. These are helping,
assisting, and putting in place measures that will guide the coping strategies of breast
cancer patients. The information gained in this study will additionally help fill the gap in
the literature on the assessment levels of depression and anxiety and how this assessment
impact treatment outcome for breast cancer patients undergoing radiotherapy.
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Recommendations
Recommendations for Action
For the useful implementation of the results, a summary will be disseminated to
the three Oncology Centers in the country. This process will improve the knowledge of
the breast cancer management and as well the coping mechanisms for patients in these
categories. In doing this, the overall team members involved in the disease management
will be more observant, vigilant and open to proceed with the suitable interventions and
referrals as and when needed. A summary of these findings will also be available in
written form, available in English and Twi, for patients with the contact details of the
investigator in case they may have any questions. Each patient participant contributed to
the study, and therefore these feedback regarding the results is necessary.
One recommendation which is keen will be for the Government and the Ministry
of Health to place breast cancer treatment (Surgery, Chemotherapy, and Radiotherapy) on
the NHIS. This request will be a significant relief for patients and family and will in
effect cause patients to report early to the hospital. It will also help caregivers appreciate
the survival of their patients on treatment and improve satisfaction to work. Another
recommendation is getting free mandatory breast cancer screening services for patients in
Ghana. This will also help see patients early and improve survival of patients. Finally,
there are few oncology practitioners (30) in Ghana managing all cancer cases across the
length and breadth of the nation. I recommend the training of more staff, or possibly
sponsor more people who will show interest but have no financial support to undergo this
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program. This training in effect will improve patient-to-staff ratio and overall affect the
care given to patients.
Recommendations for Further Study
The study confirmed higher levels of anxiety and depression among breast cancer
patients undergoing radiotherapy treatment. Treatment of most of the breast cancers seen
in Ghana requires radiotherapy, and the reason for this is the late presentation. Surgery
and chemotherapy served as an adjuvant treatment before the commencement of the
radiotherapy. The predictive relationship between late presentation and anxiety and
depression were due to the factors such as cost, alternate medicine, and spirituality.
Further studies with a larger population on late presentation of breast cancer covering the
three cancer units in the country are recommended to provide an additional overview the
situation in Ghana.
Again, further study to involve anxiety and depression of breast cancer patients
from the surgery would provide support for this study's findings. Additional research may
consider broadening the risk factors of the demographics to include the medical
conditions before the presentation, medications history, stage of presentation would
provide support for the findings. Lastly, future research may embrace investigation of the
various risk factors associated with the separate items on depression and anxiety. There
were several indications of depression which were distinct from anxiety, and that could
additionally support the study’s findings.
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Concluding Statements
There is a significant relationship between the responses of breast cancer patients
undergoing radiotherapy and their level of anxiety and depression. Patients undergoing
breast cancer treatment go through several experiences such as the burden of the
treatment, high cost of treatment, and waiting time, resulting in high-level anxiety and
depression. Late presentation to treatment is common in Ghana as a consequence of the
multiplicity of reasons, affecting the overall survival of breast cancer patients. The effect
sizes of the selected participants show a strength of relationship though not every variable
was statistically significant to patients’ level of anxiety and depression. Further and
future research with a larger sample size of patients from all the three Oncology
departments within the country would shed more light on the relationships examined in
this study.
The study illustrates a need to understand how breast cancer patients in Ghana go
through treatment with the high impact of anxiety and depression with treatment which
affects total well-being and life after treatment. A further study using other cancers may
allow the multidisciplinary team to envisage how interventions could be put in place to
help entire patients cope with the disease. The success of these projections will eventually
improve patient care and the delivery of health care in Ghana. A soon as the study is
instigated, social change will have a budding realization rate.
Although interventions and management should be available to breast cancer
patients with anxiety and depression undergoing treatment for their coping with the
burden of the disease, a striking improvement in the survival of patients could be
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achieved when proper systems are put in place by the Ministry of Health and the
Government.
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Appendix A: Survey Instruments
WALDEN UNIVERSITY
COLLEGE OF HEALTH SCIENCES
SCHOOL OF PUBLIC HEALTH

Title: Assessment of Anxiety and Depression among Breast Cancer patients in Ghana
Name of Researcher:
Name of Supervisors:
Please remember that this is not a test and there no answer regarded as correct or wrong.
Individual participants may have different responses and no one will know how you
answered the questions.

If you have any concern about the study and you wish to contact someone independent,
you may contact:

Instructions: Please tick or insert the appropriate feedback

Part One: Socio-Demographic Data
1. Folder Number……………………………
2. Age ……………………………………….
3. Weight……………………………………
4. Gender: Male

[

]

Female [

]

5. Tribe………………………………………
6. Marital Status: Single [ ] Married [ ] Divorced [ ] Widowed [ ]
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7. Current occupation or last job………………………………………..
8. Current Employment status: Full time [ ] Part time [ ] Unemployed [ ] Retired [
] Student [ ]
9. Total monthly income ………………………..GH Cedis
10. Disease Duration: Less than 1 year [ ] Between 1 and 3 years [ ] Greater than 3
years [ ]
11. Family History: Yes [ ] No [ ]
Part 2A: Anxiety and Depression about your Treatment
1. I feel tense about my treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

2. I get frightened when I have to go for my treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

3. The duration of treatment makes me nervous
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

4. The waiting time makes me more anxious
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

5. I am losing interest in my appearance during my treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

6. I feel restless anytime I have to wait for my turn in treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

7. I do laugh and see the funny side of things during my treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

8. There is a worrying thoughts anytime I have to go for my treatment
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

9. I get sudden feelings of panic
Not at all [ ]

Occasionally [ ] Quite often [ ] Very often [ ]

Part 2B: Anxiety and Depression about Life during Treatment

132

1. Since the diagnosis, I am able to concentrate on what I do
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
2. I have loss of sleep over worry
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
3. I am capable of making decisions after diagnosis was made
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
4. I feel constantly under strain
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
5. I am able to enjoy day-to-day activities
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
6. I feel unhappy and depressed
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
7. I have lost confidence after the diagnosis
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
8. I now thinking of myself as worthless
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
9. I have little interest or pleasure in doing things
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
10. I feel down, depressed or hopeless
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
11. I feel bad about myself
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
12. I feel I have let my family down
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
13. I have trouble falling or staying asleep
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Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
14. I sleep too much
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
15. I feel tired and have little energy
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
16. I have poor appetite
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
17. I have troubles with concentration
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
18. I have strange thoughts that I am better off dead than alive
Not at all [ ] Several Days [ ] More than half the days [ ] Nearly every day [ ]
Part 3: Interventions of Anxiety and Depression
1. My doctor has referred me to a Cognitive-behavioral therapy (CBT) for counselling
Yes [ ] No [ ]
2. My Therapist has advised me to exercise when I feel anxious or depressed
Yes [ ] No [ ]
3. Whenever I feel depressed or anxious, I meditate
Yes [ ] No [ ]
4. Whenever I am anxious or depressed, I pray
Yes [ ] No [ ]
5. My doctor/Nurse have advised that I take my medication when I feel nervous or
depressed
Yes [ ] No [ ]
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Appendix B: Letter of Invitation for Professionals
Title of Study: Assessment of Anxiety and Depression among Breast Cancer patients in
Ghana
Name of Researcher: Kofi Adesi Kyei
Name of Supervisors:

I, Kofi Adesi Kyei, from the Department of Public Health, Walden University, invite you
to participate in a research project entitled Assessment of Anxiety and Depression among
Breast Cancer patients in Ghana.
The purpose of this research study aims to find various interventions for depression and
anxiety among breast cancer patients in Ghana. Should you choose to participate, you
will be interviewed briefly to share and provide different opinions about anxiety and
depression of the breast cancer patients under your care as they go through radiotherapy.
The expected duration for this interview will be 15 minutes
Through this the study, the quality of life of breast cancer patients undergoing
radiotherapy could improve particularly during their end-of-life stage. The expectation is
that the study will promote positive social change in the form of coping strategies, and
awareness creation, with the aim of preventing breast cancer. The latter will be through
various levels of cancer education to both the client and the caregivers. Findings from the
study could also be used to plan policies that may support methods beneficial to the
advancement of Oncological services within Ghana and Africa since many neighboring
countries within the West Africa patronize the Oncology services in Ghana. Finally, the
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possibly positive social change resulting from the study could be seen globally and
locally providing a basis for future studies, especially within the cancer setting within the
coming years on depression and anxiety.
At the end of the interview you will be contacted to review the transcript.
If you have any pertinent questions about your rights as a research participant, please
contact

Thank you,

Investigator’s Signature

…………………………
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Appendix C: Semi structured Interview Questions
E 1: Semi-structured interview questions with the Oncologists
Researcher’s questions
1. In your clinical reviews, do you get complains from patients about their level of
depression and anxiety?
2. What form of interventions do you prescribe for these patients?
3. Do you get any positive feedback as responses from these patients during next
visit or follow-up?
4. In your opinion, what can be done to improve the management of depression and
anxiety of breast cancer patients?
5. Can you share your experience with me, how you have used your method of
intervention to manage the anxiety and depression of breast cancer patients
undergoing treatment

E2: Semi-structured interview questions with the Radiotherapists
Researcher’s questions
1. In your daily treatment, do you get complains from patients on the level of
depression and anxiety?
2. What forms of interventions do you discuss with them?
3. Are there any feedback you receive from these clients?
4. Do you think the team can improve the management of anxiety and depression of
breast cancer patients?
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5. Is there anything, you will like to share with me on your experiences with
patients. Are there any peculiar interventions you have used in the past?
E3: Semi-structured interview questions with the Nurses
Researcher’s questions
1. In your weekly reviews, do you get complains from patients on the level of
depression and anxiety?
2. What forms of interventions do you discuss with them?
3. Are there any feedback you receive from the patients?
4. Do you think your team can improve the management of anxiety and depression
of breast cancer patients?
5. Is there anything, you will like to share with me on your experiences with
patients. Are there any peculiar interventions you have used in the past?
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Appendix D: Letter of Cooperation
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Appendix E: Interview with D1
Interview with Doctor Asamoah on the 4th July 2017. Asamoah is a Radiation Oncologist at the Oncology
Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and has practiced for over Five
years
Q.1. Complaints from Patients
Kofi
In your daily treatment, do you get complains from patients about their level of depression and anxiety?
Asamoah
Yes, we do normally on their weekly reviews, when the patients come in for review, some of them will not
normally speak out until you ask them. But you can tell from their body language that they are depress and
anxious about the ongoing treatment.
Sometimes, I can tell from their faces and further probe into it by asking them. Some of them open up
especially their treatment, having little idea about and on the treatment whiles others are worried about the
side effect of the therapy.
I also can tell from the level of questions they ask me in the consulting room. It tells how anxious and
depressed they are. Some ask questions about the aftermath of treatment and what will happen to them.
Whether the treatment will be effective at the end or not.
Q.2. Interventions prescribed
Kofi
What forms of advice and interventions do you prescribe for these patients?
Asamoah
Well, I think the clinic is always heavy for the breast cases and so we spend less time with patients. But
personally, I try to reassure them of the treatment and counsel them of the fact that the side effect are not
permanent and that once they finish their treatment it will end. Sometimes, I also prescribe some
medications to take care of the anxiety, and depression, some even get sleeping tablets because their sleep
is impaired.
Mostly, I think that the reassurance I give sustain them throughout their treatment.
Kofi
Let me pick up on what you said about the less informed patients. Where is that coming from, because we
know you doctors do the counselling?
Asamoah
You can identify a lot of areas, I wouldn’t say the clinic alone, but they also go through treatment every day
of the week, and some also go through chemotherapy. But mostly I think because the first point of call is
the doctors, they may have to bear that. I think we need to have more time for the patients in the clinic.
Some of the patients will also leave the clinic without any information because of the same anxiety and
depression. They will now present it as if we didn’t explain anything to them. Some of the patients also try
to do double check on the information received, hence will pretend that they have not been informed.
I think studies have even showed that financial burden of patients affect the informations they receive in the
clinic. I think to me its multi-factorial.
Q.3. Feedback from patients
Kofi
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Do you get any positive feedback as responses from patients during their next visit of follow-ups?

Asamoah
Yes patients usually get better and are less apprehensive in their next visit. Our reviews are weekly and so
by the next visit, the patients will have undergone five sessions of radiotherapy and usually, they are better,
some even will have smiles on their faces and others will also want to ask more questions.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Asamoah
Doctors and the other staff can really improve on the discussion and counselling session with patients. I
think patients need more time, though we are trying, more time for them could improve their management.
I also think that oncology department needs a clinical psychologist, it’s very important because they can see
to these patients separately.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Asamoah
There was one particular patients I saw in clinic who was concern about the darkening of her skin as a
result to radiation, sore throats and her ability to go back to work after treatment during my counselling
session. She was anxious of the outcome and as well depressed about the post treatment, family life and
coping with work.
What I personally did was to ask of her from the therapist on daily basis, spend more time with her during
review and counselling. Kept reassuring her o weekly basis through to her final day. I created a friendly
environment whenever I saw her at the clinic and that made her feel more relax to face the reality.
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Appendix F: Interview with D2
Interview with Doctor Ntiamoah on the 30th June 2017. Ntiamoah is a Radiation Oncologist at the
Oncology Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and has practiced for 5
years
Q.1. Complaints from Patients
Kofi
In your clinical reviews, do you get complains from patients about their level of depression and anxiety?
Ntiamoah
I will want to start from the from the simulation process, because we review them prior to simulation and
treatment. The simulation procedure requires that the women remove their cloths, before the process could
begin. You and I know how women cherish their breast, hence that alone makes them depressed and
anxious. Remembers that it begins the whole process, and if they are to daily remove their dress for
treatment, it certainly not a pleasant situation.
We in the clinic try to explain to them the whole process, but I think that not until they get through the
simulation, they will not see how hard it will be. These are some of the complaints patients go through.
Exposing themselves especially to male therapist is a big issue for these women. Mind you therapist in
Ghana are highly dominated by males, about 4:1 ratio.
Patients also complain about their skin marks made on their body by the therapists as a way of keeping the
treatment field. These marks according to the patients do itch, makes the anxious and sometimes form
blisters. According to these, most of the time, they are not informed about the side effects of the skin marks
and this makes them very uncomfortable even at home. This makes them more anxious.
Patients also complain of financial burden as they have to pay their treatment from the beginning through to
the end. That indeed is a mind blowing and affects their level of anxiety and makes them depressed. Most
of them say they are traders and earn very little and therefore the bill of payment is an issue for them.
Kofi
OK, what about those on treatments?
Ntiamoah
The most complains patients talk about with me is the darkening of their skin, sore throats, and fear of
death resulting from the conversations they have with other friends, relatives and other patients. Some of
the things they hear according to these patients make them more anxious and depressed and it’s even scary.
Q.2. Interventions prescribed
Kofi
What forms of advice and interventions do you prescribe for these patients?
Ntiamoah
Yes, myself for instance, I try to educate them on the disease and the entire procedure through simulation
and treatment. I try to assure them of the treatment and encourage them to go through to the end. What I
think it’s the issue is that the patients’ complaints indelible marks we put on the patients is too much and
that makes and increases their anxiety level.
With the treatment, I keep assuring them and give them the right informations. If one is not sure of any
interventions should refer to the appropriate unit.
Q.3. Feedback from patients
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Kofi
Do you get any positive feedback as responses from patients during their next visit of follow-ups?
Ntiamoah
Patients think a lot from variety of issues but besides, from their next visit or review, most of them have
become better and their confession changes. The anxiety may not be completely gone, neither the
depression, but they will still be positive.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Ntiamoah
I think that we need psychologists to handle these patients, you know the workload is much higher on the
sides of the doctors, we are few, see patients in the clinic, do brachytherapy, chemotherapy, planning, etc,
hence, it will not be enough for us to see all these patients on daily basis and have so much time for them
because of the workload. Education on patients should be all round through the treatment.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Ntiamoah
I can remember one of the patients I saw some few months ago, she came for review and I realized that she
was disturbed and so I decided to talk to her. Money to pay bill was a problem, husband was not in talking
terms with her because of the burden of the family, besides they got married not long ago.
The disease was heavy on her and that made her depressed and so I kept talking to her from one review to
the next and I think it did help her.
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Appendix G: Interview with R1
Interview with RTT Pearl on the 30th June 2017. Pearl is a Radiation Therapist at the Oncology
Department of the Korle-Bu Teaching Hospital. She lives in Accra Ghana and have practiced for Five years
Q.1. Complaints from Patients
Kofi
In your daily treatment, do you get complains from patients about their level of depression and anxiety?
Pearl
Yes, they do complain and usually the complaints on anxiety has to do with not knowing much about the
treatment. Apart from this, some of them are illiterate, so explanations might have gone on by the doctors
but by the time they get to the treatment, they may have forgotten everything. They may probably have
misunderstood all what the doctors said and refused to asked questions because of the same anxiety. Again,
just the fact that they have been diagnosed of cancer is enough to cause depression in them.
Depression has to do with in the lay man’s term ‘the person’s spirit is really down’ or one’s spirit being
dumping. But anxiety is worrying about the conditions and what is going to happen if I should explain
further. So just seeing machines at the treatment unit is enough to scare them through their treatment
trajectory.
Q.2. Interventions prescribed
Kofi
What forms of advice and interventions do you prescribe for these patients?
Pearl
Sometimes this anxiety and depression stems from not knowing what the treatment is all about. So some of
the interventions are explaining exactly what the process is all about, and letting them know that, yes the
machine is big, and scary but this is what it does to treatment. You also have to inform them that you will
be monitoring them on the machine in the control room, when they talk we can hear them and see them so
they cause for fear.
We also inform them that if they are in any form of distress, they should signal us and then we will come to
their aid. We also assure them that they will get used to the treatment within a day or two, eventually they
get used to it.
Apart from that, we advise them on their waiting, some complain about their waiting time, and the fact that
this is affecting their work which gives them earning to enable them pay their treatment cost.
Aside these, the whole stress of moving up and down and coming to the hospital for like 30days continues
is worrying to them and this is enough to cause anxiety and eventually depression.
We therefore tell them to get relief or excuse duty from work or even take some days off while’s treatment
is ongoing in order to get enough rest to cope with treatment.
We also advise them to do something they love doing in order to take their minds off all the stress they are
going through.
Q.3. Feedback from patients

Kofi
Do you get any feedback as responses from patients after these interventions?
Pearl
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Yes, we do see positive feedback, even from very difficult patients if I should put it that way. There was a
one patients who came, when she told about the treatment, her response was, she will not do it, and that she
needed to think about it with her pastor and family. She returned in a month to begin, after thorough
explanations has been given.
Eventually, she calm down after a thorough discussion we had with her, because she was somebody who
was always moody, but after the counselling, she became friendly. She was encouraged to do the treatment
by the Therapist and that was very positive.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Pearl
I believe we can improve on what we doing, especially from the Therapist point of view. Much more I
think we need a psychologist who will counsel these patients right from the start of treatment. Apart from
that, we the Oncology team have do to our best to explain into details to patients on their treatments. Their
side effects and how to handle them. We also have to encourage to inform the team whatever will be
bordering them in the course of treatment especially when they go for their reviews.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Pearl
Well, there are several angles that I can come from with the years of work experience. Some patients come
in and because at home nobody is minding them, neglected because of the disease, come in with lots of
complaints. But as you talk to them, you realize that they are in much distress.
I remember one patient, right from the start, she said she not going to do the treatment because of what she
had heard, and I had to spend extra time to counsel her. She was afraid she was going to get heart attack
because somebody told her that her heart is close to the area of treatment. She said so many things and I
had to sit her down, explain the procedure and side effects of the treatment, though I believe the doctor had
told her these things.
I advised her to pray and hope for better. She was better off after the discussions with her.
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Appendix H: Interview with R2
Interview with RTT Osei on the 30th June 2017. Osei is a Radiation Therapist at the Oncology Department
of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and have practiced over Nine years
Q.1. Complaints from Patients
Kofi
In your daily treatment, do you get complains from patients about their level of depression and anxiety?
Osei
Oh Yes, severally and sometimes they don’t really need to tell you, looking at them critically will inform
you that this patients is in some kind of distress and they need some kind of comfort and reassurance. At
times when they because of the mere fact of the breast cancer disease, you will see that they are depressed,
even from their responses to the questions you ask them.
After the explanations of the side effects, patient become even worse and that is where we come in and give
assurances and reassure of them of the treatment.
I feel that the informations we give them may be sufficient but the timing is where the problem comes.
Diagnosis is done in the consulting room, not the treatment room, so I feel when patient at the treatment has
no informations, then where the informations was given and the timing wasn’t right. The mind is usually
blogged at the consulting room to the news of the diagnosis. So in this state when counselling is ongoing,
less information is picked up from. I feel they should be given time to soak this ‘bad news’ if I should put it
that way, and then a different day is set for counselling for the treatment if the need be.
Q.2. Interventions prescribed
Kofi
What forms of interventions do you prescribe for these patients?
Osei
Most of the time, what I personally do is that when they starting the treatment I ask them whether they have
any idea of the side effects of the treatment and some will boldly say NO.
Meanwhile, you know that these patients have signed consent and the moment that has been done, patients
should have idea of the side effects. But, like I said the counseling doesn’t go really well with them because
of the news of cancer. So patients like these will have to go through counselling again from me. When I see
that they are still not satisfied with the explanations, I refer them back to the doctor.
Kofi
Do you think the counseling should be a one-time thing or should be a daily basis?
Osei
Well, for me I think our weekly review is enough, and meanwhile we the therapist also counsel patients on
daily basis as they go through their treatment, so I think that is fine. However, a trained counsellor will help
in this.
Q.3. Feedback from patients
Kofi
Do you get any feedback as responses from patients after these interventions?
Osei
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Yes, most of the time I will say its 90% positive. Those who do not put their minds to the reassurances we
give them of course will have issues. Along the line of treatment, they come back to us and we explain
further on their questions. Some of the patients by reason of listening to friends and other patients get
themselves more confused. Because imagine a cervical patients telling a breast patients some of the side
effects she is experiencing. This breast patient may feel she will experience same side effects. This is where
some take further burden of depression and anxiety so if they do not come back to tell you their feedback,
then they go through like this and suffer.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Osei
I think we should get a psychologist or another different doctor to do the counselling, it should not be the
same doctor who broke the bad news to them. I think that is the only thing we are missing out.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Osei
Most of the patients have been treated personally, I sometimes give my personal numbers to call in times of
any distress and have had a good time with some of them. I sometimes even call to verify how they are
doing, though I will not mention names, I think it’s been cordial with them and the responses have been
positive.
There was one patient that did not want to do the treatment but I advised her to go through the treatment
and that her refusal to undergo treatment may progress the disease and she may get worse. Initially, this
was difficult but she agreed and went through. Later after her treatment, she came to thank me and was so
grateful to the team.
The other patients told me frankly that her pastor advised her not to undergo the treatment. This I also took
it upon myself to explain to patients, it was not easy from the beginning, but she finally agreed and
underwent the treatment. She was also grateful to me at the end.
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Appendix I: Interview with N1
Interview with Nurse Reginald on the 29th June 2017. Reginald is an Oncology Nurse at the Oncology
Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and have practiced for Six years
Q.1. Complaints from Patients
Kofi
In your weekly reviews, do you get complains from patients about their level of depression and anxiety?
Reginald
For depression and anxiety, we’ve got a lot of complain from most if not all the patients undergoing chemo
radiation. I think the first complain I will mention is the diagnosis of breast cancer in itself. That is a Killer
if I should put it that way. This alone, will for the rest of the patient life lead to levels of anxiety and
depression.
The second thing I will talk about is their financial commitment to the treatment. The chemotherapy drugs
are very expensive and patients sometimes or most times go through that for six cycles, with a cycle not
less than GH 1500 or USD 400. This is minus the laboratory investigation before and after each cycle. This
is just for the chemo, so if you add radiation therapy and surgery, it’s way too expensive for an average
Ghanaian. Most of the breast cancer patients are low or middle income earners and are predominantly petty
traders, hence this will be too hard for them to bear resulting in psychological depression and anxiety.
Others also complain that cancer is a death sentence and that news they hear of friends and other people is
an indication to this. This in effect increases their anxiety and depression as they are constantly afraid.
Some of the patients when they undergo adjuvant chemotherapy where chemo is done before surgery, their
worry always is whether their breast will be cut or not.
Q.2. Interventions prescribed
Kofi
What forms of interventions do you discuss with these patients?
Reginald
Our chemo suits has stages, and the first stage is the counselling for the patients and with this we dive
through and discuss every possible side effect and their related interventions as and when they show up.
Chemotherapy drugs are very strong and poses several side effect, one of which is the loss of hair. This is
mind blowing and therefore I take my time to explain to patients and provide possible avenues through this.
I personally also try to debunk any negative information they have heard from people concerning the
treatment, like “you will die’, ‘they will cut your breast’, ‘your hair will be gone’ and the likes. Rather, I
explain the ‘why’ to every patients and the advantages they get if they consent to undergo.
We also try to inform them of cancer survival groups who have gone through similar treatment and are now
doing well in life. We also try and introduce the first timers to the chemo suits to allay every anxiety and
then inform them of the level of competence of the supporting staff group. Aside that we also give
assistance in the form of introductory letters on request from patients to their work places for financial
support and the feedback has been positive. Aside these we also provide letters on request for patients to
churches and other societal organizations for help. Once a while, we do get philanthropist coming through
to settle some bills for patients.
All these in one way or the other help patients cope with their anxiety and depression.
Q.3. Feedback from patients
Kofi
Do you get any feedback as responses from these patients?
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Reginald
Oh, we have a positive feedback, for example those with financial burden by their next visit will be smiling
and cheerful especially when they get support from people. Also, by their next chemo visit, if even they
may have complaints, they will look more friendly, and open-up, because of the various interventions
discussed.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Reginald
I think I can only speak from my unit. One thing that I can think of is that you know in most companies or
hospitals, they have Psychologists and Cognitive behavioral therapist who help in the counselling. So what
I can say is that if the department can arrange with the hospital in getting at least one of these to be
stationed in the Centre, it will do a lot of good to our patients.
Again, the oncology nurse could be sponsored to take extended programs or courses pertaining to psychooncology, so that they can help patients with their level of anxiety and depression. We could also have a
training session with a trained specialist or a researcher who has done a research into these areas for the
staff to help them manage patients well.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Reginald
This is a very good question, what I normally do is that when they come to the chemo suit for the first time,
I interact with them, because I see that as relieve to patients and then they can open up. I personally talk to
them about their spirituality because of what I believe. Off course we have variety of patients, some are
Christians, Muslims, and other traditionalist, but I try to let them know that cancer diagnosis is not a death
sentence and that is actually not the end of the world.
What I have seen is that when I start on that level, patients are able to open up to me, talk to me more, they
feel more relaxed, and that reduces their anxiety and depression level.
They are so happy, I give them my contacts and chart with them as and when they call me

149

Appendix J: Interview with N2
Interview with Nurse Enam on the 30th June 2017. Enam is an Oncology Nurse at the Oncology
Department of the Korle-Bu Teaching Hospital. She lives in Accra Ghana and has practiced for Seven
years
Q.1. Complaints from Patients
Kofi
In your clinical reviews, do you get complains from patients about their level of depression and anxiety?
Enam
Yes, just severally, just recently I have had a patients ask a lot of questions about the chemotherapy,
apparently she has gone to read about the condition and the management as well as the side effects and was
worried about a whole lot of things that she feels may happen to him. She expressed concern, anxious and
doesn’t know how long she will live. The effects of the drugs. I have also come across patients who are so
depressed of the effects of the chemotherapy on them. According to them, they have lost their hair, their
finger nails are burnt, and they have several issues with the drug.
Q.2. Interventions prescribed
Kofi
What forms of advice and interventions do you prescribe for these patients?
Enam
This was a patient who felt she was not informed about the condition properly by all the doctors that she
had met and as a result presented to the oncology late. Her stage was advanced and that means her survival
was small. Upon coming to the Oncology department, she has to go through the treatment but the trauma of
the whole issue is what is killing plus the fact that she has been told she has few months to live.
As a Nurse, have tried to talk to this patient lengthy and have spoken the doctors and my superiors about it.
She is so anxious, though she has not asked anything about death, you can look at her and see so much
distress.
Q.3. Feedback from patients
Kofi
Do you get any positive feedback as responses from patients during their next visit of follow-ups?
Enam
The chemotherapy unit of the department is a small and most times there is very little time you have with
patients because of the number, space and time. However, the little time we get we do discuss the feedback
of patients and usually, they complain of several side effects that makes them weaker and more
apprehensive.
Q.4. Management
Kofi
In your opinion, what can be done to improve the management of the depression and anxiety of breast
cancer patients?
Enam
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There could be a section prior to chemotherapy for counseling where concerns of patients could be
addressed. There could also be a talk for breast cancer patients at the outpatients department, may be if it is
even 5minutes prior to their session for the chemotherapy, it can really help. This when done routinely, can
allay anxiety because the information they read elsewhere, from friends, relatives, family, could affect them
and make them more depressed and anxious. However, if they hear these from us, they know that well, it is
from the right source.
Another thing that could be done, is to get a handout that contains informations on coping with treatment
and other related issues with breast cancer and share them for these patients.
I also see pastors in the morning praying with some of the patients and I believe that also help with those
who believe in these.
Q.5. Share your experience
Kofi
Can you share your experience with me, how you have used your method of interventions described to
manage the anxiety and depression of patients undergoing treatment.
Enam
My experiences with some of the patients have been through counselling, predominantly because I am
mostly in the chemo suit and usually hear patients and see their mood. As and when I get them I talk to
them on coping principles and taking care of themselves after treatment.

